This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Medicines for HER+ breast cancer
RX_ERPLUS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
15869 |
4. Check minimum number of events
Min. number of events
3
|
15869 |
5. Include endpointsNone |
15869 |
6. Filter based on genotype QC (FinnGen only) |
15869 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Medicines for HER+ breast cancer
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 15869 | 15625 | 244 |
| Unadjusted period prevalence (%) | 5.25 | 5.33 | 0.11 |
| Median age at first event (years) | 61.21 | 61.40 | 49.56 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 13199
- Matched controls
- 131614
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L03AA14
ATC
lipegfilgrastim; parenteral
14.7
323.0
1082
796
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
25.1
323.0
2858
1433
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
39.3
323.0
464
122
C50
ICD-10 Finland
Malignant neoplasm of breast
26.6
323.0
2102
930
JN4BD
NOMESCO Finland
Extensive body CT
4.7
323.0
2707
6827
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
24.8
323.0
1391
622
L03AA13
ATC
pegfilgrastim; parenteral
19.9
323.0
2702
1680
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
31.8
323.0
513
167
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
54.1
323.0
606
117
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
17.9
323.0
1604
1011
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
33.0
323.0
2008
712
1CD02
NOMESCO Finland
NA
53.6
323.0
699
137
HAE99
NOMESCO Finland
Other reconstruction of breast
18.2
323.0
533
303
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
23.2
323.0
1688
825
394
Kela drug reimbursment
Palbociclib
394.1
323.0
498
13
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
25.0
323.0
1309
577
A03FA01
ATC
metoclopramide; systemic, rectal
8.1
323.0
7458
18272
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.2
323.0
9469
38403
A04AA02
ATC
granisetron; systemic, transdermal
15.2
323.0
3412
2950
L02BA01
ATC
tamoxifen; oral
549.1
323.0
6308
219
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
30.5
323.0
2072
800
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.9
323.0
857
1311
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
91.9
323.0
522
59
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
24.8
323.0
1199
528
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
18.9
323.0
684
379
N63
ICD-10 Finland
Unspecified lump in breast
4.2
323.0
1899
5027
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
79.0
323.0
761
102
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
46.1
323.0
1701
420
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
49.9
323.0
4311
1266
ZX090
NOMESCO Finland
Other technic of radiotherapy
15.0
323.0
1320
966
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
20.3
323.0
678
350
192
Kela drug reimbursment
Fulvestrant
+∞
323.0
532
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
187.0
323.0
3391
243
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
12.4
323.0
626
527
X76
ICPC
Malignant neoplasm breast female
39.1
323.0
1884
558
C50.99
ICD-10 Finland
Breast, unspecified
24.2
323.0
2497
1256
L02BA03
ATC
fulvestrant; parenteral
+∞
323.0
571
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
28.5
323.0
729
269
A04AA01
ATC
ondansetron; systemic, rectal
4.2
323.0
1756
4594
L02BG06
ATC
exemestane; oral
613.3
323.0
1814
34
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
27.5
323.0
1373
553
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
18.0
323.0
2466
1660
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
23.5
323.0
3889
2296
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
15.5
323.0
1125
788
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
19.6
323.0
2639
1660
HA1AA
NOMESCO Finland
X-ray mammography
24.6
323.0
6626
5189
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
24.0
323.0
5772
4128
A04AD12
ATC
aprepitant; systemic
23.5
323.0
1469
697
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
17.0
323.0
737
457
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
44.9
323.0
6509
2794
XX1XN
NOMESCO Finland
Other isotope examination
16.4
323.0
555
351
XX2AT
NOMESCO Finland
Other injection with ultrasound examination
12.2
323.0
718
620
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
27.3
323.0
4813
2705
1501
Kela drug reimbursment
Palbociclib
445.9
323.0
560
13
HAC20
NOMESCO Finland
Total mastectomy
42.7
323.0
4657
1658
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.3
323.0
3225
4433
PJA12
NOMESCO Finland
Sentinel node biopsy
42.5
323.0
7833
4372
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
26.5
323.0
1981
870
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
27.5
323.0
1875
789
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
24.6
323.0
879
380
WF003
NOMESCO Finland
Adjuvant radiotherapy
12.3
323.0
1706
1563
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
40.5
323.0
1354
370
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.2
323.0
5276
18118
TQW20
NOMESCO Finland
Tatoe
27.4
323.0
955
373
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.8
323.0
4789
3074
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
15.8
323.0
587
387
L01XE33
ATC
[U] palbociclib; oral
1050.8
323.0
409
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
13.5
323.0
1645
1378
R4110
NOMESCO Finland
Physiotherapy
2.4
323.0
4563
23637
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.1
323.0
1451
2622
L02BG03
ATC
anastrozole; oral
564.5
323.0
2149
45
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
23.4
323.0
1400
665
H02AB02
ATC
dexamethasone; systemic
18.3
323.0
6146
5995
PJW99
NOMESCO Finland
Other operation on lymphatic system
54.1
323.0
421
80
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
12.4
323.0
879
753
ZX080
NOMESCO Finland
Image guided radiotherapy
16.0
323.0
1155
784
WZC30
NOMESCO Finland
Teaching
3.0
323.0
2483
9433
A04AA55
ATC
palonosetron, combinations; systemic
21.2
323.0
2279
1285
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
26.5
323.0
1263
523
ZX120
NOMESCO Finland
Intravenous
4.1
323.0
2209
6094
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
24.8
323.0
3921
2204
115
Kela drug reimbursment
Breast cancer
992.2
323.0
12459
2202
Z31.5
ICD-10 Finland
Genetic counselling
6.2
323.0
1513
2687
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
28.0
323.0
609
227
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
29.2
323.0
1315
496
XX3DW
NOMESCO Finland
Time consuming IT work
6.7
323.0
3311
6223
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
26.9
323.0
1134
459
L02BG04
ATC
letrozole; oral
264.6
323.0
8770
980
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
16.0
323.0
740
488
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.0
323.0
1443
488
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
29.1
323.0
468
166
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.7
323.0
6782
29031
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
38.2
323.0
1522
447
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
46.1
323.0
1492
363
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
11.8
323.0
861
776
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
17.8
323.0
1976
1285
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
20.9
323.0
3504
2235
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
323.0
5773
35486
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
20.2
323.0
1814
1031
ZZF00
NOMESCO Finland
Graft of adipose tissue
18.7
321.1
507
281
M05BX04
ATC
denosumab; parenteral
4.0
319.2
1417
3863
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
22.5
316.4
469
215
ZZR10
NOMESCO Finland
Flap of skin and muscle
18.9
312.6
491
268
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.7
310.7
956
1779
ZX112
NOMESCO Finland
Subcutaneous
9.1
310.6
684
785
C50.12
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,lobular tumor
49.5
308.2
377
78
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
23.5
305.6
447
196
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.9
301.2
631
662
TQB05
NOMESCO Finland
Puncture of skin of trunk
17.7
300.1
483
282
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
33.7
299.3
397
121
L01EF01
ATC
palbociclib; oral
502.8
298.5
297
6
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
26.8
295.0
415
159
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
37.4
290.5
376
103
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
12.6
289.5
537
442
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
25.0
276.6
397
163
Z51.0
ICD-10 Finland
Radiotherapy session
14.4
275.8
481
344
C50.52
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor
47.0
275.3
340
74
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
35.8
273.1
357
102
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
12.2
268.1
505
429
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
5.7
267.0
824
1532
L03AA02
ATC
filgrastim; parenteral
6.3
266.8
758
1270
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
10.5
264.8
536
526
HA3AT
NOMESCO Finland
Pucture of mammary gland cyst with ultrasound examination
18.9
258.5
406
221
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
15.5
258.3
437
290
FM1FN
NOMESCO Finland
Heart function isotope examination
23.4
251.6
368
161
WX702
NOMESCO Finland
Supraglottic ventilation device
3.8
250.2
1162
3265
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
27.5
246.4
344
128
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
41.6
245.1
310
76
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.1
241.8
703
1211
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
15.9
239.8
401
258
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.7
239.5
1141
3271
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
19.6
237.7
368
192
HA1BG
NOMESCO Finland
MRI examination of mammary gland with high intensity magnet
15.4
235.3
399
266
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
28.4
233.5
323
116
WX402
NOMESCO Finland
General anaesthesia
2.3
231.4
2593
12737
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
26.9
223.7
314
119
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
19.3
223.7
348
184
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
20.7
221.0
336
166
ZXA05
NOMESCO Finland
Left side
1.9
220.7
4009
24075
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.6
217.0
816
1878
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
24.1
215.4
312
132
1XC03
NOMESCO Finland
NA
40.3
214.5
273
69
ZXA00
NOMESCO Finland
Right side
1.9
211.3
4197
25946
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
37.9
211.0
272
73
HA1BA
NOMESCO Finland
Extensive X-ray mammography
14.9
208.8
358
245
L02AE02
ATC
leuprorelin; implant, parenteral
10.0
207.0
429
439
L02AE03
ATC
goserelin; implant
11.8
204.8
390
338
HA1HA
NOMESCO Finland
Tomosynthesis mammography
17.2
204.7
332
197
N02BE01
ATC
paracetamol; systemic, rectal
2.3
204.2
11864
104725
B01AB05
ATC
enoxaparin; parenteral
1.8
202.4
4625
29913
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
23.2
202.0
296
130
A79
ICPC
Malignancy NOS
9.9
200.3
419
436
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
17.0
199.6
325
195
L01BC06
ATC
capecitabine; oral
4.3
193.3
766
1852
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
192.2
3785
23152
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
14.8
190.3
327
225
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
17.7
190.0
305
176
N06AX16
ATC
venlafaxine; oral
2.2
188.5
2232
11127
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.6
188.3
925
2702
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.1
181.8
427
541
HAC25
NOMESCO Finland
Radical mastectomy
18.8
180.9
284
154
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
25.2
179.3
256
103
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
12.4
178.4
332
274
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
9.2
178.0
386
428
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
30.2
177.3
241
81
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
9.5
176.3
377
408
HAD99
NOMESCO Finland
Other plastic operation on breast
13.4
175.0
314
239
8522/3-C50.9
ICD-O-3
Infiltrating duct and lobular carcinoma of breast, NOS
86.3
174.5
196
23
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
18.3
173.2
274
152
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
172.1
5697
40732
JN4AD
NOMESCO Finland
Body CT examination
2.8
170.9
1194
4471
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
20.7
170.7
259
127
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
12.1
170.4
320
269
L01CA04
ATC
vinorelbine; systemic
13.7
168.0
298
221
HA2AT
NOMESCO Finland
Cytology of mammary gland with ultrasound guidance
17.2
163.5
265
157
HAD40
NOMESCO Finland
Mastopexy
14.4
163.3
284
201
HWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of mammary gland
21.8
163.0
243
113
HA1SA
NOMESCO Finland
Expansion mammography
18.3
161.8
256
142
X21
ICPC
Breast sympt/compl female other
4.8
161.5
566
1205
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
160.8
1467
6394
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
36.7
156.6
203
56
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
26.9
155.7
218
82
X19
ICPC
Breast lump/mass female
5.5
150.1
471
885
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
5.2
150.1
493
977
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
9.9
146.1
304
313
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
10.6
144.7
290
278
HWH99
NOMESCO Finland
Other reoperation in surgery of mammary gland
21.8
142.9
213
99
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
20.5
142.8
217
107
L02BA02
ATC
toremifene; oral
703.9
142.0
140
*
8520/3-C50.2
ICD-O-3
Lobular carcinoma, NOS, of upper-inner quadrant of breast
52.0
140.6
170
33
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
138.7
5362
39203
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.3
137.4
750
2364
C50.32
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor
40.7
136.5
173
43
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
9.4
133.8
286
309
Z3231
NOMESCO Finland
Registered nurse
1.7
132.6
3541
23315
M05BA02
ATC
clodronic acid; systemic
23.0
127.8
187
82
C50.93
ICD-10 Finland
Malignant tumor in other specified localization in mammary gland other or unspecified histology
27.2
127.7
178
66
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
6.8
125.6
331
497
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
3.4
125.4
663
2038
R50.9
ICD-10 Finland
Fever, unspecified
2.0
123.7
1704
8913
A02BC02
ATC
pantoprazole; systemic
1.6
123.0
8848
74326
JN4CD
NOMESCO Finland
Very extensive body CT
3.4
122.7
633
1908
HA1RA
NOMESCO Finland
Combined assessment of mammary gland (mammography and ultrasound)
4.1
118.3
488
1218
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
30.8
115.7
156
51
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.8
113.8
339
598
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.9
113.5
393
824
8520/3-C50.8
ICD-O-3
Lobular carcinoma, NOS, of overlapping lesion of breast
80.6
113.2
128
16
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
11.6
112.3
214
186
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
17.0
109.3
177
105
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
7.7
108.8
262
345
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
9.4
108.3
231
249
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
38.6
107.9
138
36
X26
ICPC
Fear of breast cancer female
7.9
107.8
256
330
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
18.1
107.3
170
95
Z3226
NOMESCO Finland
Physiotherapist
1.7
104.7
2510
15826
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
16.8
103.3
168
101
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.7
102.2
477
1325
XX1AD
NOMESCO Finland
Other CT-examination
10.7
101.7
202
191
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
7.0
100.5
259
377
8520/3-C50.1
ICD-O-3
Lobular carcinoma, NOS, of central portion of breast
57.0
100.2
119
21
C50.30
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication
22.1
99.4
147
67
8480/3-C50.9
ICD-O-3
Mucinous adenocarcinoma of breast, NOS
27.6
98.9
137
50
A46
ICD-10 Finland
Erysipelas
1.9
98.4
1625
9049
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.0
98.3
334
686
8520/3-C50.5
ICD-O-3
Lobular carcinoma, NOS, of lower-outer quadrant of breast
51.6
97.7
118
23
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
96.1
1461
7887
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
96.0
886
3841
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
3.6
95.5
463
1327
3AA13
NOMESCO Finland
NA
22.2
92.9
137
62
J01DB01
ATC
cefalexin; oral
1.5
92.4
10392
92771
ZSZ10
NOMESCO Finland
Secondary repair operation
40.9
90.4
114
28
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.7
90.3
216
282
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
10.0
89.7
184
185
PJ1AN
NOMESCO Finland
Lymphsystem isotope imaging
24.6
88.8
127
52
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.1
88.8
293
583
Z51.5
ICD-10 Finland
Palliative care
2.5
88.2
742
3059
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
14.0
88.1
154
111
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
9.9
88.0
182
186
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
18.0
84.7
134
75
QBJ00
NOMESCO Finland
Liposuction in trunk
8.4
84.5
192
231
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
84.2
1696
10062
8522/3-C50.4
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast
37.4
84.1
108
29
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
83.8
925
4361
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
83.3
650
2570
B01AB10
ATC
tinzaparin; parenteral
2.1
82.4
1022
5070
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.5
80.9
526
10957
HAF00
NOMESCO Finland
Excision of local recurrence of breast cancer
56.7
80.9
96
17
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
15.7
80.5
134
86
N62
ICD-10 Finland
Hypertrophy of breast
2.4
77.9
729
3176
N02AA05
ATC
oxycodone; systemic
1.7
77.4
1746
10706
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
3.7
76.4
351
962
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
18.5
75.5
118
64
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
13.9
74.4
130
94
J01MA12
ATC
levofloxacin; systemic
1.6
72.4
2112
13890
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
72.1
1141
6216
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
70.1
11523
106962
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.0
68.7
287
725
C50.5
ICD-10 Finland
Malignant neoplasm: Lower-outer quadrant of breast
15.2
68.4
115
76
C50.01
ICD-10 Finland
Malignant tumor of nipple and areola, ductal tumor
16.7
68.4
111
67
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.4
68.0
154
185
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
5.0
66.8
224
455
WF004
NOMESCO Finland
Palliative radiotherapy
4.1
66.7
270
663
ZZQ70
NOMESCO Finland
Free microvascular graft of lymph nodes
69.1
66.1
76
11
QBA00
NOMESCO Finland
Puncture of skin of trunk
9.2
62.8
134
146
ZXE00
NOMESCO Finland
One hour or less
1.4
62.2
4817
38655
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.5
62.1
308
899
PG1BD
NOMESCO Finland
Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft
60.1
61.4
72
12
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
61.0
666
3115
WC205
NOMESCO Finland
Simple therapy of local tumor recidive with hormone
160.3
60.9
64
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.9
59.8
389
1375
SPAT1269
SPAT
Other puncture and/or drainage
6.5
58.8
157
242
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
23.4
58.2
84
36
B29
ICPC
Lymph/immune mech sympt/complt other
8.4
58.1
131
157
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.9
57.4
249
651
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.1
57.4
339
1126
HA1DA
NOMESCO Finland
Restricted mammography
15.5
56.5
94
61
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
56.4
890
4829
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
56.2
728
3660
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
14.4
54.2
93
65
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.1
53.1
626
3025
HAD20
NOMESCO Finland
Liposuction of breast
12.9
52.4
94
73
S18
ICPC
Laceration/cut
1.3
52.0
4961
40808
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.3
51.7
278
865
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
7.4
51.4
125
169
WX110
NOMESCO Finland
Local anesthesy
1.3
51.1
8244
73214
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.8
49.9
958
5547
8520/3-C50.3
ICD-O-3
Lobular carcinoma, NOS, of lower-inner quadrant of breast
53.7
49.5
59
11
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
14.9
49.2
83
56
LCA06
NOMESCO Finland
Biopsy of endometrium
1.5
48.9
1999
14097
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
11.1
48.3
93
84
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
6.2
48.0
133
216
HAD00
NOMESCO Finland
Augmentation mammoplasty
17.1
47.0
75
44
ZSP00
NOMESCO Finland
Procedure related to previous procedure classified in chapter P
24.0
46.9
67
28
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
12.0
46.4
86
72
WX704
NOMESCO Finland
Intubation
1.8
46.0
834
4739
WX400
NOMESCO Finland
Inhalation anesthesy
2.1
44.8
527
2546
9703
FHL
Breast resection
3.4
44.7
224
662
1742A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-inner quadrant
9.4
43.9
92
98
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
4.4
43.0
161
369
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
4.5
42.9
156
347
N05CF01
ATC
zopiclone; oral
1.3
42.6
4067
33171
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.4
42.3
359
1485
N64.9
ICD-10 Finland
Disorder of breast, unspecified
3.4
41.9
209
615
WF002
NOMESCO Finland
Radical radiotherapy
2.4
41.7
359
1497
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
41.7
729
4091
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
41.4
1393
9381
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
41.1
351
1454
HAA10
NOMESCO Finland
Biopsy of mammary gland
3.7
40.9
182
489
1DB03
NOMESCO Finland
NA
90.1
40.7
45
5
1XC13
NOMESCO Finland
NA
36.5
39.9
51
14
C50.3
ICD-10 Finland
Malignant neoplasm: Lower-inner quadrant of breast
13.2
39.7
70
53
D24
ICD-10 Finland
Benign neoplasm of breast
2.4
39.7
346
1453
HA1DM
NOMESCO Finland
Mammary gland very extensive MRI examination with 3 Tesla magnet
27.0
39.3
54
20
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
39.2
2218
16590
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
39.1
708
4015
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
39.0
2365
17900
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.8
38.7
7136
78939
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
8.9
38.6
83
93
Z31.6
ICD-10 Finland
General counselling and advice on procreation
8.0
38.6
89
112
SPAT1152
SPAT
Removal of foreign body from under the skin
2.3
38.3
357
1549
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.5
38.2
1270
8518
8523/3-C50.9
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of breast, NOS
30.0
38.1
51
17
RD211
NOMESCO Finland
NA
1.9
37.8
543
2837
5BX04
NOMESCO Finland
NA
46.0
37.7
46
10
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
12.9
37.6
67
52
H01CC01
ATC
ganirelix; parenteral
3.2
37.1
202
636
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.6
37.0
271
1034
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
5.2
36.9
116
222
OAA41
NOMESCO Finland
Health check based on individual needs
12.0
36.8
68
57
1515
Kela drug reimbursment
NA
82.1
36.7
41
5
3030
Kela drug reimbursment
Abemaciclib
82.1
36.7
41
5
N61
ICD-10 Finland
Inflammatory disorders of breast
2.5
36.6
290
1155
C50.09
ICD-10 Finland
Malignant tumor of nipple and areola, other or undeterminated histology
16.8
35.7
57
34
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
8.1
35.6
81
100
JN5AN
NOMESCO Finland
Total body isotope imaging
28.2
35.4
48
17
ZZS55
NOMESCO Finland
Distension of tissue expander
32.9
35.2
46
14
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
5.6
35.2
104
185
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.3
34.7
181
553
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.6
34.6
163
460
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
4.8
34.4
117
244
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
13.8
33.6
58
42
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.2
33.6
131
314
1BC02
NOMESCO Finland
NA
50.0
33.4
40
8
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
5.8
33.3
96
166
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
38.2
33.3
42
11
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.5
33.3
260
1031
D05.0
ICD-10 Finland
Lobular carcinoma in situ
7.2
32.7
80
111
8523/3-C50.4
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast
24.2
32.6
46
19
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
32.6
847
5341
8211/3-C50.9
ICD-O-3
Tubular adenocarcinoma of breast, NOS
17.0
32.2
51
30
8524/3-C50.4
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-outer quadrant of breast
72.1
31.8
36
5
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
164.9
31.6
33
*
XX2ET
NOMESCO Finland
NA
21.9
31.6
46
21
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
6.1
31.5
87
143
WB610
NOMESCO Finland
Demanding neoadjuvant therapy of tumour with antibodies
11.8
31.4
58
49
XX9TE
NOMESCO Finland
Compementary ultrasound examination
4.1
31.2
124
303
G03GA05
ATC
follitropin alfa; parenteral
2.6
31.2
236
919
L01EF03
ATC
abemaciclib; oral
69.8
30.8
35
5
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
9.9
30.6
62
63
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
30.6
1018
6817
QCJ00
NOMESCO Finland
Liposuction in upper limb
16.3
30.5
49
30
HAD10
NOMESCO Finland
Augmentation of breast using prosthesis
6.0
30.2
85
143
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
2.5
30.1
246
1000
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
3.6
30.1
141
398
HA1AE
SPAT
NA
2.5
30.0
242
976
8507/3-C50.4
ICD-O-3
Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast
58.3
30.0
35
6
ZX001
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - SSD therapy
32.5
29.9
39
12
8480/3-C50.4
ICD-O-3
Mucinous adenocarcinoma of upper-outer quadrant of breast
28.6
29.7
40
14
N97.0
ICD-10 Finland
Female infertility associated with anovulation
3.1
29.6
171
563
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
29.5
847
5473
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.1
29.4
163
522
JN6AD
NOMESCO Finland
CT of torso and neck
3.1
29.3
162
519
128
Kela drug reimbursment
Cancers of female genital organs
2.2
29.0
319
1497
WE200
NOMESCO Finland
Profylactive therapy of malignancy with hormones
291.8
28.7
29
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
28.7
589
3472
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
27.9
4806
41629
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
6.1
27.9
77
127
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
7.0
27.7
69
99
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
27.7
276
1239
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.9
27.5
389
2024
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
2.8
27.2
175
621
WW500
NOMESCO Finland
Blood transfusion
1.9
27.1
395
2078
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.6
27.0
614
9268
8522/3-C50.1
ICD-O-3
Infiltrating duct and lobular carcinoma of central portion of breast
61.9
26.9
31
5
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
6.6
26.9
70
107
A21
ICPC
Risk factor for malignancy
9.2
26.7
56
61
8010/3-C50.9
ICD-O-3
Carcinoma, NOS, of breast, NOS
6.3
26.6
71
112
GA5AA
NOMESCO Finland
Rib X-ray examination
5.4
26.4
80
148
C50.61
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, ductal tumor
22.3
26.4
38
17
SPAT1153
SPAT
Removal of sutures
1.3
26.3
3690
31170
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
26.1
797
5229
8524/3-C50.9
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of breast, NOS
40.0
25.7
32
8
HAA01
NOMESCO Finland
Suture of mammary gland
26.9
25.7
35
13
ZSZ00
NOMESCO Finland
Primary repair operation
13.8
25.7
44
32
WF099
NOMESCO Finland
Other radiotherapy
4.5
25.5
92
206
L95
ICPC
Osteoporosis
1.7
25.4
496
2882
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
25.4
1089
14680
THA00
NOMESCO Finland
Needle biopsy of mamilla
7.1
25.3
62
87
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.7
25.2
534
3180
5702
FHL
Local lymph node removal (eg armpit, groin)
4.6
24.9
88
193
M05BA06
ATC
ibandronic acid; systemic
2.0
24.9
334
1706
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
16.2
24.4
39
24
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.7
24.3
174
659
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.6
24.2
491
7598
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.3
24.1
219
942
B01AC04
ATC
clopidogrel; oral
0.7
23.7
665
9648
A08
ICPC
Swelling
1.7
23.7
489
2891
8522/3-C50.2
ICD-O-3
Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast
31.0
23.6
31
10
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.7
23.4
165
620
156
Kela drug reimbursment
Lapatinib
21.2
23.3
34
16
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
5.1
23.2
74
146
9706
FHL
Ablation mammae, includes axillary exploration
5.7
23.2
67
118
ULC02
NOMESCO Finland
Hysteroscopy
1.5
23.1
786
5283
N05CB02
ATC
barbiturates in combination with other drugs
1.8
23.1
421
2395
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.4
23.0
112
328
L01XE07
ATC
[U] lapatinib; oral
24.6
23.0
32
13
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.3
22.9
116
350
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
4.4
22.9
84
192
TLW00
NOMESCO Finland
Insemination
3.1
22.5
125
404
C10AA05
ATC
atorvastatin; oral
0.8
22.4
3063
35747
1741A
ICD-9 Finland
Malignant neoplasm of female breast, Central portion
11.7
22.3
41
35
QBJ99
NOMESCO Finland
Other aesthetic correction of skin of trunk
14.8
22.3
37
25
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
3.1
22.3
124
401
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
15.7
22.2
36
23
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
7.1
22.1
54
76
J94.8
ICD-10 Finland
Other specified pleural conditions
2.7
22.1
149
546
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.7
22.1
553
8200
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
5.6
22.0
64
114
QBA10
NOMESCO Finland
Incision of skin of trunk
3.1
22.0
121
389
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
21.7
3756
32315
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
10.5
21.7
42
40
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.5
21.1
717
4819
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
6.7
20.9
53
79
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
20.8
1206
8987
HA1ST
NOMESCO Finland
Biopsy of mammary gland with sterotactic guidance
6.6
20.7
53
80
8480/3-C50.2
ICD-O-3
Mucinous adenocarcinoma of upper-inner quadrant of breast
37.1
20.7
26
7
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
8.8
20.7
44
50
5BA08
NOMESCO Finland
NA
3.8
20.7
88
232
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
20.6
782
5380
WW200
SPAT
NA
0.7
20.6
542
7963
C10AA01
ATC
simvastatin; oral
0.8
20.5
3691
42029
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.2
20.5
109
343
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
4.7
20.5
70
150
ZXD20
NOMESCO Finland
Day surgery
1.3
20.1
1458
11250
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
20.1
891
11975
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
19.9
405
2385
1CD01
NOMESCO Finland
NA
6.1
19.8
54
89
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
10.0
19.7
39
39
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
19.5
1306
9954
LA2AE
NOMESCO Finland
Ultrasound examination of ovarian cyst
2.7
19.5
130
475
TLW12
NOMESCO Finland
Insertion of frozen embryo
3.4
19.3
94
277
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
5.0
19.2
61
121
WB321
NOMESCO Finland
Multiple adjuvant therapy of malignancy with biomodifiers
15.5
19.2
31
20
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.9
19.1
116
399
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
19.1
4445
39248
A14AB01
ATC
nandrolone; parenteral
5.7
19.0
54
94
Z2221
NOMESCO Finland
Medical doctor
1.2
19.0
3024
25724
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.7
19.0
759
10369
A04AA03
ATC
tropisetron; systemic
4.2
18.9
72
172
M05BA04
ATC
alendronic acid; oral
1.4
18.9
1168
8788
N05CF02
ATC
zolpidem; oral
1.3
18.9
2089
17051
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.2
18.9
192
876
Z2446
NOMESCO Finland
Social worker
1.5
18.8
579
3805
S76
ICPC
Skin infection other
1.6
18.4
489
3102
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.6
18.3
521
3361
1745A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-outer quadrant
7.1
18.2
44
62
C08CA01
ATC
amlodipine; oral
0.8
18.1
2953
34023
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
0.6
18.1
309
4962
N46
ICD-10 Finland
Male infertility
9.7
18.0
36
37
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.1
18.0
99
320
QWF00
NOMESCO Finland
Reoperation for insufficiency of suture in plastic surgery of skin
12.3
18.0
32
26
B04
ICPC
Blood symptom/complaint
4.0
18.0
71
176
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.7
18.0
351
2045
NK6SN
NOMESCO Finland
Bone SPECT
12.9
17.8
31
24
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
17.6
724
5061
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.8
17.5
322
1841
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
17.5
355
2089
8246/3-C50.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of breast, NOS
179.7
17.5
18
*
L02AB01
ATC
megestrol; oral (progestogens)
179.7
17.5
18
*
G03GA01
ATC
chorionic gonadotrophin; parenteral
1.7
17.4
330
1904
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
3.0
17.3
101
340
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.4
17.3
144
595
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.8
17.3
1377
17120
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
17.0
1994
16376
XX2VW
NOMESCO Finland
Radiologic consultation
3.5
16.9
80
232
AN1
HP
Coronary angiography
0.7
16.6
474
6864
NF3AA
NOMESCO Finland
Femur X-ray examination
2.1
16.6
192
927
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.5
16.6
130
523
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
12.6
16.5
29
23
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.3
16.5
1310
10228
X79
ICPC
Benign neoplasm breast female
7.6
16.5
38
50
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
16.5
1856
22207
R92
ICD-10 Finland
Abnormal findings on diagnostic imaging of breast
3.2
16.4
85
264
8522/3-C50.5
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast
20.0
16.4
24
12
X62
ICPC
Female Genital, Administrative procedure
39.9
16.3
20
5
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
16.1
1157
8900
ZZR00
NOMESCO Finland
Flap of skin
1.9
16.1
222
1150
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.2
16.1
164
749
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.7
16.0
108
398
N97
ICD-10 Finland
Female infertility
4.8
16.0
53
111
E0000UV
ATC
NA
1.2
16.0
4507
40286
XX9XW
NOMESCO Finland
NA
3.4
15.9
78
233
C507
ICD-10 Finland
NA
13.5
15.9
27
20
L09
ICPC
Arm symptom/complaint
1.6
15.8
453
2927
SPAT1211
SPAT
Application of soft bandage
1.4
15.8
910
6767
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
15.8
739
5301
T85.4
ICD-10 Finland
Mechanical complication of breast prosthesis and implant
4.8
15.7
52
109
PJ5YQ
NOMESCO Finland
NA
15.6
15.6
25
16
1748X
ICD-9 Finland
Malignant neoplasm of female breast, Other specified sites of female breast
6.1
15.6
42
69
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
15.6
1137
14304
TPX15
NOMESCO Finland
Removal of vascular injection port
3.8
15.6
66
175
Z08
ICD-10 Finland
Follow-up examination after treatment for malignant neoplasms
9.7
15.6
31
32
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
15.5
373
2305
TJA10
NOMESCO Finland
Laparocentesis
4.6
15.5
53
115
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
3.8
15.5
66
176
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.3
15.4
1482
11865
M54.4
ICD-10 Finland
Lumbago with sciatica
0.8
15.3
1212
15090
ZX100
NOMESCO Finland
Oral
2.3
15.3
134
572
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
5.2
15.1
46
88
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
8.6
15.1
32
37
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
15.1
250
1386
L58.9
ICD-10 Finland
Radiodermatitis, unspecified
17.7
15.1
23
13
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.8
15.1
925
11891
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.1
15.0
172
831
C10AA07
ATC
rosuvastatin; oral
0.8
14.9
1949
23004
N81.1
ICD-10 Finland
Cystocele
0.7
14.7
634
8563
Y16
ICPC
Breast symptom/complaint male
18.3
14.6
22
12
E29.1
ICD-10 Finland
Testicular hypofunction
13.1
14.6
25
19
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
0.6
14.5
191
3266
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
14.3
193
993
P01BA02
ATC
hydroxychloroquine; oral
0.7
14.3
618
8351
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
1.8
14.2
238
1322
L04AX01
ATC
azathioprine; systemic
0.6
14.2
159
2832
G03GA09
ATC
corifollitropin alfa; parenteral
7.3
14.1
33
45
8522/3-C50.8
ICD-O-3
Infiltrating duct and lobular carcinoma of overlapping lesion of breast
42.4
14.1
17
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.9
13.8
213
1151
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
2.4
13.8
119
506
HAD55
NOMESCO Finland
Incision of periprosthetic capsule of breast
11.3
13.7
25
22
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
2.3
13.7
127
559
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
2.1
13.7
148
700
WB213
NOMESCO Finland
Adjuvant hormone therapy of malignancy
139.7
13.4
14
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
10.0
13.4
26
26
WE100
NOMESCO Finland
Profylactic cytostatic therapy
12.8
13.3
23
18
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
13.3
2955
25806
SPAT1324
SPAT
Screening procedure
0.8
13.1
1644
19505
8140/3-C50.9
ICD-O-3
Adenocarcinoma, NOS, of breast, NOS
6.8
13.1
32
47
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
13.1
745
5531
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
4.0
13.0
51
128
Z31.3
ICD-10 Finland
Other assisted fertilization methods
8.7
12.9
27
31
A06AH03
ATC
naloxegol; oral
2.4
12.9
104
429
Z44.3
ICD-10 Finland
Fitting and adjustment of external breast prosthesis
19.0
12.9
19
10
L03.3
ICD-10 Finland
Cellulitis of trunk
2.8
12.8
81
290
C50.62
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, lobular tumor
49.9
12.8
15
*
W15
ICPC
Infertility/subfertility female
4.7
12.7
42
89
ZX121
NOMESCO Finland
Central venous catheter
3.6
12.7
55
151
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
0.5
12.6
84
1741
C10AX09
ATC
ezetimibe; oral
0.7
12.6
603
8026
1514
Kela drug reimbursment
NA
69.7
12.6
14
*
3002
Kela drug reimbursment
Ribociclib
69.7
12.6
14
*
8480/3-C50.1
ICD-O-3
Mucinous adenocarcinoma of central portion of breast
31.9
12.5
16
5
9702
FHL
Breast exploration and possible tumor removal
1.8
12.5
225
1282
N06AX11
ATC
mirtazapine; oral
1.2
12.5
3588
31963
G03AC03
ATC
levonorgestrel; systemic
1.2
12.5
1701
14168
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
2.7
12.4
83
308
J01FF01
ATC
clindamycin; systemic
1.2
12.4
2812
24568
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
1.5
12.4
491
3412
8524/3-C50.2
ICD-O-3
Infiltrating lobular mixed with other types of carcinoma of upper-inner quadrant of breast
129.7
12.4
13
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
7.9
12.3
27
34
205
Kela drug reimbursment
Chronic hypertension
0.8
12.2
2074
23958
ZX050
NOMESCO Finland
Stereotactic radiotherapy
3.2
12.2
63
198
1AA01
NOMESCO Finland
NA
8.4
12.2
26
31
N64.5
ICD-10 Finland
Other signs and symptoms in breast
1.7
12.2
262
1576
Z31.2
ICD-10 Finland
In vitrofertilization
3.4
12.1
57
167
HAB30
NOMESCO Finland
Excision of mamilla or areola
7.4
12.1
28
38
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.6
12.1
290
1799
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
1.9
12.1
175
929
C50.02
ICD-10 Finland
Malignant tumor of nipple and areola, lobular tumor
12.3
12.1
21
17
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
12.1
261
1572
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
5.4
12.0
35
65
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
0.5
12.0
76
1601
G03GA30
ATC
gonadotropins - combinations; systemic
7.2
11.9
28
39
WE198
NOMESCO Finland
Palliative cystotatic therapy
9.2
11.9
24
26
C01DA14
ATC
isosorbide mononitrate; oral
0.8
11.9
724
9324
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
3.2
11.9
60
186
8523/3-C50.2
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of upper-inner quadrant of breast
46.5
11.8
14
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.8
11.8
200
1118
8460/3-C56.9
ICD-O-3
Low grade serous carcinoma of ovary
7.0
11.7
28
40
9719
FHL
Other measure in this category
3.9
11.6
46
117
HA1DT
NOMESCO Finland
Mammary gland biopsy with MRI guidance
29.9
11.6
15
5
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.6
11.5
175
2884
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.7
11.5
444
6099
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
2.9
11.4
68
236
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
3.3
11.4
55
165
M53.1
ICD-10 Finland
Cervicobrachial syndrome
0.8
11.4
738
9428
N81.6
ICD-10 Finland
Rectocele
0.8
11.4
640
8332
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.6
11.4
80
307
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.5
11.3
341
2239
XX9CN
NOMESCO Finland
NA
15.0
11.3
18
12
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
15.0
11.3
18
12
N64.8
ICD-10 Finland
Other specified disorders of breast
2.7
11.3
75
278
HAA00
NOMESCO Finland
Incision of mammary gland
5.3
11.2
33
62
B01AB04
ATC
dalteparin; parenteral
1.4
11.2
478
3374
HAD57
NOMESCO Finland
Resection of periprosthetic capsule of breast
8.8
11.2
23
26
8480/3-C50.5
ICD-O-3
Mucinous adenocarcinoma of lower-outer quadrant of breast
24.9
11.1
15
6
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
4.7
11.1
36
76
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
3.7
11.0
47
128
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
6.4
11.0
28
44
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.5
11.0
84
1666
TLW10
NOMESCO Finland
Transfer of fresh embryo
2.5
10.9
84
337
A10AA02
ATC
NA
0.5
10.7
79
1584
8211/3-C50.4
ICD-O-3
Tubular adenocarcinoma of upper-outer quadrant of breast
10.5
10.7
20
19
ZXC90
NOMESCO Finland
Use of absorbable mesh in surgery
17.7
10.7
16
9
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
3.9
10.7
42
107
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
0.6
10.7
185
2957
335
Kela drug reimbursment
Lapatinib
21.4
10.6
15
7
G03GA02
ATC
human menopausal gonadotrophin; parenteral
1.7
10.6
213
1261
N02AJ06
ATC
codeine and paracetamol; systemic
1.1
10.6
3901
35310
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
5.9
10.5
28
47
N05BA04
ATC
oxazepam; oral
1.2
10.5
2767
24430
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
11.2
10.5
19
17
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
0.7
10.5
282
4123
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.3
10.5
873
6857
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
0.7
10.4
409
5610
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.2
10.4
1314
10846
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.4
10.4
472
3371
TQX05
NOMESCO Finland
Skin puncture, unspecified location
4.2
10.4
38
91
M48.0
ICD-10 Finland
Spinal stenosis
0.8
10.3
839
10436
9710
FHL
Existence of a relapse
16.0
10.3
16
10
8507/3-C50.5
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-outer quadrant of breast
32.4
10.3
13
*
8503/3-C50.9
ICD-O-3
Intraductal papillary adenocarcinoma with invasion of breast, NOS
32.4
10.3
13
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
4.0
10.3
40
101
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
10.3
1792
20678
ZXF20
NOMESCO Finland
Interruption caused by problems of surgical technique
6.3
10.3
26
41
L71
ICPC
Malignant neoplasm musculoskeletal
8.7
10.2
21
24
1XC14
NOMESCO Finland
NA
23.3
10.2
14
6
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.1
10.2
5545
51432
I25.2
ICD-10 Finland
Old myocardial infarction
0.6
10.2
129
2216
ZXA10
NOMESCO Finland
Bilateral
1.2
10.1
2025
17474
J05AB11
ATC
valaciclovir; oral
1.2
10.1
1402
11686
R06AE07
ATC
cetirizine; oral
1.1
10.0
5193
48002
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
10.0
58
199
A55
ICPC
General and Unspecified, Local injection/infiltration
2.5
10.0
78
318
KMAK
NOMESCO Finland
NA
0.9
9.9
4915
52786
XX9KE
NOMESCO Finland
Ultrasound examination with contrast
7.2
9.9
23
32
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
3.0
9.9
57
193
R60.0
ICD-10 Finland
Localized oedema
1.2
9.9
1107
9015
N05BA06
ATC
lorazepam; systemic, sublingual
1.4
9.9
459
3298
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
0.7
9.9
431
5811
8097/3-C44.3
ICD-O-3
Basal cell carcinoma, nodular of skin of other and unspecified parts of face
7.6
9.8
22
29
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
2.6
9.8
70
270
8523/3-C50.5
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast
25.9
9.8
13
5
1740A
ICD-9 Finland
Malignant neoplasm of female breast, Nipple and areola
8.1
9.8
21
26
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
20.0
9.8
14
7
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
3.6
9.7
42
117
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.0
9.7
120
604
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
1.9
9.7
133
698
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
0.8
9.7
519
6795
1XC0V
NOMESCO Finland
NA
54.9
9.6
11
*
8523/3-C50.8
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of overlapping lesion of breast
54.9
9.6
11
*
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
5.1
9.6
29
57
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
3.8
9.6
39
103
L88
ICPC
Rheumatoid/seropositive arthritis
0.7
9.6
212
3217
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
0.7
9.6
391
5326
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
4.7
9.6
31
66
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
2.9
9.5
55
187
M70.6
ICD-10 Finland
Trochanteric bursitis
0.8
9.5
1220
14477
TLC02
NOMESCO Finland
Simple extraction of IUD
1.4
9.5
407
2877
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.2
9.5
90
404
L04AA13
ATC
leflunomide; oral
0.6
9.5
121
2077
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.4
9.5
75
308
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
2.4
9.5
78
327
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.2
9.5
1033
8390
N39.3
ICD-10 Finland
Stress incontinence
0.8
9.4
691
8700
A07EC01
ATC
sulfasalazine; oral, rectal
0.7
9.4
488
6422
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.8
9.4
1474
17176
8523/3-C50.1
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of central portion of breast
99.8
9.4
10
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
9.4
293
4170
G47.3
ICD-10 Finland
Sleep apnoea
0.8
9.4
1236
14627
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.3
9.4
83
360
8523/3-C50.3
ICD-O-3
Infiltrating duct mixed with other types of carcinoma of lower-inner quadrant of breast
+∞
9.4
9
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.6
9.4
248
1583
OAB42
SPAT
NA
0.6
9.3
181
2819
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.7
9.3
202
1224
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
3.9
9.3
37
96
PJW20
NOMESCO Finland
Lymphovenous shunt
12.3
9.3
16
13
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
1.8
9.3
155
868
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.6
9.2
112
1947
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
9.2
2521
22295
LEF13
NOMESCO Finland
Colpoperineoplasty and vaginal hysterectomy
0.7
9.2
217
3244
N02AA01
ATC
morphine; systemic, rectal
2.3
9.1
83
368
L04AB01
ATC
etanercept; parenteral
0.4
9.1
32
834
H02AB04
ATC
methylprednisolone; systemic
0.8
9.1
1169
13873
I20.09
ICD-10 Finland
Unstable angina
0.6
9.1
187
2876
R18
ICD-10 Finland
Ascites
1.7
9.1
164
942
X77
ICPC
Malignant neopl genital female other
2.9
9.0
52
177
ZXC82
NOMESCO Finland
Microsurgical
8.2
9.0
19
23
RF210
NOMESCO Finland
NA
1.5
9.0
266
1742
OAB47
SPAT
NA
0.5
9.0
71
1387
8541/3-C50.9
ICD-O-3
Paget disease and infiltrating duct carcinoma of breast of breast, NOS
36.6
9.0
11
*
8507/3-C50.1
ICD-O-3
Invasive micropapillary carcinoma of breast of central portion of breast
36.6
9.0
11
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.7
9.0
410
5489
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.0
8.9
105
519
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.7
8.8
267
3816
C10AA04
ATC
fluvastatin; oral
0.8
8.8
518
6700
A10AA01
ATC
NA
0.5
8.7
58
1194
WC401
NOMESCO Finland
Simple antibody therapy of local recurrence of tumour
7.1
8.7
20
28
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.4
8.7
39
113
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
3.3
8.5
40
120
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.2
8.5
926
7522
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
10.0
8.5
16
16
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
27.4
8.5
11
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.9
8.4
1964
22194
N03AG01
ATC
valproic acid; systemic, rectal
0.7
8.4
267
3790
N85.9
ICD-10 Finland
Noninflammatory disorder of uterus, unspecified
2.1
8.4
92
441
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
0.8
8.4
451
5904
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
2.4
8.4
69
293
J02AC01
ATC
fluconazole; systemic
1.1
8.3
5493
51314
OAB39
NOMESCO Finland
Sexual health guidance
12.7
8.3
14
11
OAB44
SPAT
NA
0.6
8.3
121
2006
P20
ICPC
Memory disturbance
0.8
8.3
769
9421
R31
NOMESCO Finland
Adaptation training
5.0
8.3
25
50
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
10.7
8.3
15
14
1743A
ICD-9 Finland
Malignant neoplasm of female breast, Lower-inner quadrant
5.5
8.2
23
42
QBE35
NOMESCO Finland
Repair of skin defect in trunk after surgery or injury
4.4
8.2
28
64
HAC99
NOMESCO Finland
Other mastectomy
14.4
8.2
13
9
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.9
8.2
1900
21475
R51.80
ICD-10 Finland
Headache
0.8
8.2
1052
12477
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
2.7
8.2
52
190
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
0.7
8.2
298
4128
A02BC05
ATC
esomeprazole; systemic
1.1
8.1
4771
44259
R10.1
ICD-10 Finland
Pain localized to upper abdomen
0.8
8.1
1319
15334
I10
ICD-10 Finland
Essential (primary) hypertension
0.9
8.1
5882
62107
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
0.7
8.1
233
3355
G43
ICD-10 Finland
Migraine
0.6
8.1
145
2295
HAF99
NOMESCO Finland
Other operation for local recurrence of breast cancer
33.3
8.1
10
*
M54.2
ICD-10 Finland
Cervicalgia
0.7
8.0
411
5412
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
2.6
8.0
53
200
HA1S1
NOMESCO Finland
Photography of breasts
4.1
8.0
29
70
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.4
8.0
43
951
ZX002
NOMESCO Finland
Simple dose design for radiotherapy based on tomography - isocentric therapy
8.9
8.0
16
18
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
3.6
8.0
34
95
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
1.7
8.0
145
836
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.4
8.0
41
919
Z31.1
ICD-10 Finland
Artificial insemination
3.5
7.9
35
101
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.1
7.9
40
128
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
0.8
7.9
668
8262
C09AA05
ATC
ramipril; oral
0.9
7.9
1713
19459
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.7
7.8
299
4109
158
Kela drug reimbursment
Everolimus
6.1
7.8
20
33
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
3.9
7.8
30
77
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
0.4
7.8
37
855
WX707
NOMESCO Finland
Fiberoscopic intubation
3.3
7.8
37
113
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.7
7.8
140
809
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
4.6
7.8
25
54
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
0.6
7.7
90
1576
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.3
7.7
67
292
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.1
7.7
2357
20992
HA3RT
NOMESCO Finland
Coagulation of mammary neoplasm under radiological guidance
6.3
7.7
19
30
WX725
NOMESCO Finland
Noninvasive ventilation
1.4
7.6
376
2732
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
3.4
7.6
34
99
RF190
NOMESCO Finland
NA
8.0
7.6
16
20
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.6
7.5
188
1187
L01XE10
ATC
[U] everolimus; oral
10.0
7.5
14
14
N97.9
ICD-10 Finland
Female infertility, unspecified
1.4
7.5
300
2103
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
0.5
7.5
60
1161
318
Kela drug reimbursment
Teriparatide
0.2
7.5
8
376
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.2
7.4
796
6454
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.9
7.4
4574
48789
L03
ICPC
Low back symptom/complaint
0.9
7.4
2157
24026
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
2.5
7.4
56
228
SGA01
NOMESCO Finland
Tooth opening as first aid
0.8
7.4
945
11222
HAD41
NOMESCO Finland
Transposition of areola
79.9
7.4
8
*
8522/3-C50.3
ICD-O-3
Infiltrating duct and lobular carcinoma of lower-inner quadrant of breast
79.9
7.4
8
*
M77.1
ICD-10 Finland
Lateral epicondylitis
0.7
7.4
375
4944
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.9
7.4
1699
19226
C50.0
ICD-10 Finland
Malignant neoplasm: Nipple and areola
6.4
7.4
18
28
N05AX08
ATC
risperidone; systemic
0.7
7.4
358
4745
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
0.7
7.4
169
2538
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
1.6
7.3
167
1031
L01EF02
ATC
ribociclib; oral
+∞
7.3
7
*
ZZS50
NOMESCO Finland
Insertion of tissue expander
10.8
7.3
13
12
ZZR70
NOMESCO Finland
Perforator flaps
10.8
7.3
13
12
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.7
7.3
151
911
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
1.8
7.2
122
691
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
0.6
7.2
150
2296
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
0.7
7.2
350
4634
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.1
7.1
5383
50510
HAF10
NOMESCO Finland
Repair after excision of local recurrence of breast cancer using graft or flap
29.9
7.1
9
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
0.6
7.1
105
1731
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
12.0
7.1
12
10
K30
ICD-10 Finland
Functional dyspepsia
0.8
7.0
798
9581
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
0.5
7.0
50
1006
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
0.6
7.0
124
1964
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.5
7.0
64
1193
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
0.7
7.0
275
3760
L04AA06
ATC
mycophenolic acid; systemic
0.4
7.0
35
790
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
0.7
6.9
334
4432
AN4
HP
Balloon angioplasty and drug eluding stent
0.5
6.9
64
1188
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.8
6.9
710
8608
ZXD05
NOMESCO Finland
Urgent procedure
1.1
6.9
2794
25320
M54.5
ICD-10 Finland
Low back pain
0.9
6.9
3006
32693
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
0.7
6.9
173
2554
A87
ICPC
Complication of medical treatment
2.1
6.9
74
356
Z31.4
ICD-10 Finland
Procreative investigation and testing
2.9
6.9
38
130
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.5
6.9
52
212
G44.2
ICD-10 Finland
Tension-type headache
0.8
6.9
1072
12504
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.7
6.8
212
3009
J01MA02
ATC
ciprofloxacin; systemic
1.1
6.8
3868
35741
T89
ICPC
Diabetes insulin dependent
0.6
6.8
107
1734
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
5.0
6.8
20
40
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
0.3
6.7
10
388
8931/3-C54.1
ICD-O-3
Endometrial stromal sarcoma, low grade of endometrium
16.6
6.7
10
6
XX3XT
NOMESCO Finland
Other labeling with other radiological guidance
16.6
6.7
10
6
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
5.6
6.7
18
32
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.8
6.7
888
10502
00044
NOMESCO Finland
NA
22.4
6.7
9
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.9
6.6
1504
17048
E66.8
ICD-10 Finland
Other obesity
0.7
6.6
269
3662
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.2
6.6
1233
10563
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
3.1
6.6
33
106
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
0.8
6.6
407
5226
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
1.4
6.6
360
2668
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.9
6.6
1834
20496
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
0.7
6.5
328
4327
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
0.9
6.5
2588
28308
D70.81
ICD-10 Finland
Neutropenia congenital
8.6
6.5
13
15
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.7
6.5
140
2128
M35.3
ICD-10 Finland
Polymyalgia rheumatica
0.7
6.5
207
2928
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.3
6.5
466
3598
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
4.8
6.5
20
42
N99.3
ICD-10 Finland
Prolapse of vaginal vault after hysterectomy
0.6
6.5
120
1877
H05AA02
ATC
teriparatide; parenteral
0.2
6.5
8
342
SPAT1229
SPAT
Assessment of need for aid
1.2
6.5
772
6343
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
1.9
6.4
90
479
L06
ICPC
AXILLA SYMPTOMS/COMPLAINTS
6.1
6.4
16
26
TGA30
NOMESCO Finland
Thoracocentesis
2.4
6.4
50
209
Y78
ICPC
Malign neopl male genital other
69.7
6.4
7
*
C50.6
ICD-10 Finland
Malignant neoplasm: Axillary tail of breast
69.7
6.4
7
*
L02BG01
ATC
aminoglutethimide; oral
69.7
6.4
7
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.6
6.4
109
1735
R03AC02
ATC
salbutamol; inhalant
0.9
6.3
5474
57580
E66.00
ICD-10 Finland
Metabolic syndrome
0.7
6.3
242
3323
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
1.7
6.3
112
644
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.3
6.3
415
3162
A26
ICPC
Fear of cancer, NOS
2.3
6.3
57
253
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
3.4
6.3
28
83
SPAT1059
SPAT
Spirometry at the office
0.7
6.3
275
3697
C10AA03
ATC
pravastatin; oral
0.8
6.2
416
5289
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
18.0
6.2
9
5
WC225
NOMESCO Finland
Demanding therapy of local tumor recidive with hormone
18.0
6.2
9
5
3AF02
NOMESCO Finland
NA
+∞
6.2
6
*
M907, C5041
ICD-10 Finland
NA
+∞
6.2
6
*
8507/3-C50.8
ICD-O-3
Invasive micropapillary carcinoma of breast of overlapping lesion of breast
+∞
6.2
6
*
8507/3-C50.3
ICD-O-3
Invasive micropapillary carcinoma of breast of lower-inner quadrant of breast
+∞
6.2
6
*
X81
ICPC
Genital neopl female other/unspecif
3.7
6.2
25
68
C08CA13
ATC
lercanidipine; oral
0.8
6.2
997
11605
C50.60
ICD-10 Finland
Malignant tumor of the scapula of the mammary gland, no histological veryfication
26.6
6.2
8
*
8500/3-C50.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of nipple
26.6
6.2
8
*
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
0.8
6.2
362
4679
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
0.8
6.2
375
4825
C08CA05
ATC
nifedipine; systemic
0.8
6.2
317
4167
ZYC01
SPAT
NA
0.7
6.2
240
3288
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
2.5
6.2
44
173
N97.8
ICD-10 Finland
Female infertility of other origin
1.9
6.2
80
417
A10AE05
ATC
insulin detemir; parenteral
0.7
6.2
212
2958
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.2
6.1
753
6200
M03BC01
ATC
orphenadrine (citrate); systemic
0.9
6.1
1983
21961
A40.1
ICD-10 Finland
Sepsis due to streptococcus, group B
3.6
6.1
25
69
ZYC01
NOMESCO Finland
Remote contact by phone
1.3
6.1
349
2607
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
0.8
6.1
561
6876
R5110
SPAT
NA
1.4
6.1
238
1666
N05AX12
ATC
aripiprazole; systemic
0.6
6.1
100
1604
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
4.6
6.1
19
41
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
1.7
6.1
124
749
I20.90
ICD-10 Finland
Angina pectoris, unspecified
0.6
6.0
117
1813
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
1.9
6.0
77
400
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
0.3
6.0
15
447
I20.01
ICD-10 Finland
Unstable angina
0.5
6.0
52
984
SPAT1255
SPAT
Intravenous administration of medicine
1.3
6.0
517
4091
WGA10
NOMESCO Finland
Measurement of pain intensity
6.7
6.0
14
21
LCA10
NOMESCO Finland
Curettage of body of uterus
1.4
6.0
315
2322
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
9728
70454
1.89
311.67
6.8
6.0
mmol/l
1.2
1.2
27.80
8000
59241
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
3647
1634
27.93
307.65
4.3
2.3
u/ml
42.3
30.4
2.69
3530
1569
(3002256) Pathology report gross observation
4496
16899
3.22
307.65
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
4229
13845
3.69
307.65
4.1
3.7
ug/l
14.1
25.4
2.14
3264
10993
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1364
3439
4.13
307.65
1.2
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
874
541
16.60
307.65
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
6685
33654
2.62
307.65
9.6
6.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
12188
69191
4.09
307.65
9.8
5.4
umol/l
9.2
10.5
45.07
11939
64930
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
2113
1041
22.66
307.65
4.8
2.2
u/ml
56.0
39.8
2.02
2098
1021
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
9346
61234
2.18
307.65
3.7
3.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
1853
601
33.87
307.65
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
3517
2995
14.41
307.65
1.3
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
12094
76477
3.27
307.65
13.1
8.7
e9/l
3.5
4.0
157.48
11198
66184
(40768804) Tissue Pathology biopsy report
9115
58608
2.21
307.65
2.4
2.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
7004
41361
2.16
307.65
2.1
2.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
1012
1388
7.52
307.65
1.6
1.3
nmol/l
0.3
0.4
0.75
654
996
(4035726)
5097
10916
6.23
307.65
1.4
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
8910
48390
2.81
307.65
6.6
2.9
mmol/l
2.4
2.4
49.99
8237
41359
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
14517
104896
5.09
307.65
12.1
7.0
u/l
78.4
78.4
0.05
14267
97733
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
2476
11084
2.39
304.87
4.3
3.6
u/ml
54.1
60.1
0.50
2401
10687
(40768795) Lymph node Pathology biopsy report
635
1237
5.17
295.86
1.1
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
8938
63778
1.84
291.44
5.5
5.3
mmol/l
1.2
1.2
44.90
8361
57046
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
502
817
6.15
283.46
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
4998
31909
1.77
218.43
3.9
4.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
4887
31555
1.73
201.85
2.1
2.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2318
12183
2.00
182.98
1.7
2.1
g/l
0.2
0.2
28.18
2228
11299
(3018418) pH of Serum or Plasma
6091
42803
1.63
176.10
4.6
3.7
ph
7.4
7.4
9.13
1542
7499
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
409
881
4.62
168.62
1.8
1.5
ug/l
4.2
5.5
0.57
297
639
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
642
2024
3.18
153.10
1.4
1.3
u/l
37.2
38.2
0.26
599
1598
(3023323) Follitropin [Units/volume] in Serum or Plasma
1331
6156
2.21
145.67
1.5
1.3
iu/l
37.8
37.3
0.24
1155
5382
(3024561) Albumin [Mass/volume] in Serum or Plasma
7766
59577
1.53
142.74
3.9
4.4
g/l
35.6
35.6
0.06
7266
54870
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
8074
63340
1.49
127.29
2.3
2.3
nmol/l
82.2
1535.2
0.50
7482
56350
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
2016
11421
1.82
122.90
4.3
3.4
mmol/l
1.2
1.2
7.03
1884
9746
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
14137
126788
1.79
110.23
17.8
12.7
ml/min/173m2
80.6
78.7
31.32
12783
103374
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
634
2465
2.57
102.02
1.2
1.2
—
—
—
0
0
(40758358) Immune stain study
82
46
17.45
98.78
1.0
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
14606
133190
1.86
94.99
16.9
13.8
mg/l
21.4
21.3
0.12
12147
104682
(3042936) Bacteria identified in Isolate by Culture
2627
17248
1.58
89.63
1.8
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
4420
32599
1.44
85.40
1.4
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
445
1640
2.69
79.66
1.2
1.2
u/l
60.0
58.7
0.22
282
1106
(3019225) pH of Specimen
2185
14345
1.56
73.15
4.6
4.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
456
1814
2.49
69.80
1.5
1.2
u/l
16.1
19.3
3.50
390
1477
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
3709
27339
1.42
69.09
2.9
2.9
mmol/l
2.5
2.5
12.40
3333
23798
(3033658) Prothrombin time (PT) actual/Normal
4411
33717
1.38
65.70
3.4
3.6
%
95.4
94.8
1.04
4304
32787
(3019550) Sodium [Moles/volume] in Serum or Plasma
14917
138771
1.78
64.20
17.1
15.6
mmol/l
139.7
139.7
0.03
14675
135157
(3023103) Potassium [Moles/volume] in Serum or Plasma
14924
139095
1.76
60.40
17.2
15.8
mmol/l
3.9
3.9
4.87
14659
135226
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1964
13217
1.51
57.59
3.4
3.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
15140
142078
1.83
54.44
15.8
10.5
u/l
24.5
23.9
2.64
14920
136525
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
236
764
3.04
53.75
1.2
1.1
u/l
73.9
84.0
1.25
211
593
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
236
767
3.03
53.39
1.2
1.1
u/l
18.0
24.5
1.23
209
577
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2719
20245
1.37
44.87
1.7
1.8
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
258
968
2.62
44.67
1.6
1.5
u/l
5.5
6.3
0.34
128
457
(3005082) Progesterone [Moles/volume] in Serum or Plasma
128
316
3.97
44.36
2.1
1.3
nmol/l
30.5
30.3
0.03
123
266
(3017446) Testosterone [Moles/volume] in Serum or Plasma
268
1052
2.51
42.30
3.2
1.7
nmol/l
9.9
6.6
4.89
245
867
(3044889) 12 lead EKG panel
10664
95343
1.27
41.69
3.7
3.7
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
68
108
6.16
39.44
1.6
1.2
nmol/l
0.2
0.4
1.24
43
64
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
107
255
4.11
38.95
2.8
1.6
pmol/l
230.1
139.4
4.59
100
231
(3001556) Androgen free Index in Serum or Plasma
44
42
10.23
38.91
1.5
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5173
42946
1.26
36.92
4.2
3.1
u/l
35.9
32.3
1.41
4933
40565
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
386
1897
2.01
35.35
1.5
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
233
943
2.43
34.52
1.2
1.2
u/l
16.1
23.5
1.51
207
798
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
235
961
2.40
34.03
1.2
1.2
u/l
70.6
83.6
1.56
215
838
(3032080) INR in Blood by Coagulation assay
6063
51836
1.23
31.55
7.3
7.8
inr
1.2
1.2
1.13
1842
14632
(3013826) Glucose [Moles/volume] in Serum or Plasma
8684
77009
1.22
31.19
3.8
4.3
mmol/l
6.5
6.6
4.29
8228
71872
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
12543
127836
0.79
29.91
3.7
4.0
mmol/l
1.3
1.3
3.16
11159
116051
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
13492
136201
0.77
29.00
4.8
5.1
mmol/l
2.9
2.9
0.38
12133
124811
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
476
2678
1.75
28.63
2.8
1.9
u/l
2917.7
4053.6
0.69
259
1076
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
3808
31235
1.25
28.58
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
11951
109894
1.24
28.38
22.5
16.7
%
13.8
13.7
5.58
11840
107473
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
13085
132502
0.78
27.78
4.2
4.5
mmol/l
1.6
1.6
1.26
11780
121345
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
13204
133515
0.78
27.25
4.2
4.6
mmol/l
4.9
4.9
0.85
11947
122874
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
799
5204
1.52
26.63
1.8
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
223
996
2.20
26.38
1.5
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
462
2640
1.73
26.32
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
462
2640
1.73
26.32
1.2
1.3
—
—
—
0
0
(3013512) EKG study
4733
40033
1.22
25.97
3.8
3.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
562
3413
1.63
25.40
1.5
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
5363
45995
1.21
25.31
4.7
6.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
12301
125091
0.81
24.29
5.3
5.8
mmol/mol
39.4
39.5
0.34
11165
115001
(40765089) Chromosome analysis panel - Blood by G-banded
57
124
4.49
23.47
1.0
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
637
4067
1.55
23.27
2.6
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1957
15169
1.29
22.98
1.6
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2215
26389
0.79
22.75
1.2
1.3
u/ml
9.6
13.4
2.09
824
10011
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
724
4777
1.50
22.68
1.7
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2333
27601
0.79
22.53
1.3
1.3
iu/ml
35.3
38.5
0.36
726
9036
(3003434) Protein [Mass/volume] in Pleural fluid
258
1297
1.95
22.31
1.4
1.4
g/l
35.5
32.6
3.58
238
1172
(40761511) CBC panel - Blood by Automated count
14574
138145
1.34
21.50
16.2
12.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
6732
59550
1.18
21.03
11.0
9.3
e9/l
0.0
0.0
1.88
5541
48626
(3051651) Icteric interference index of Serum or Plasma
167
729
2.24
21.00
2.4
3.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
7242
64603
1.17
19.97
5.0
6.2
%
27.2
28.7
24.51
6738
59767
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
46
96
4.68
19.96
1.3
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1688
20479
0.78
19.86
1.3
1.4
titre
536.3
582.1
0.50
361
4712
(3004809) Band form neutrophils/100 leukocytes in Blood
346
1981
1.72
19.67
2.0
3.3
%
2.5
1.3
5.77
260
1556
(3019069) Monocytes/100 leukocytes in Blood
7082
63158
1.17
19.36
5.2
6.4
%
8.6
8.4
5.54
6638
58770
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
451
2779
1.60
19.27
1.3
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1783
13965
1.27
19.07
1.6
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
3674
40889
0.84
18.64
3.6
3.8
mg/mmol
6.8
7.5
0.33
1944
23061
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
434
2675
1.60
18.54
1.4
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
131
548
2.34
18.27
2.0
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1774
13970
1.27
18.09
1.7
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
343
2013
1.67
17.83
1.4
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
7021
62846
1.16
17.64
4.9
6.1
%
2.7
2.8
5.22
6537
58159
(3012441) Differential panel - Pleural fluid
195
976
1.96
17.20
1.4
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
3506
38931
0.84
16.98
2.9
3.1
mg/l
424.3
496.2
0.34
1869
21782
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2600
21481
1.21
16.93
3.1
3.0
mmol/l
0.8
0.8
0.62
2416
19805
(3019150) Specific gravity of Urine by Refractometry
2640
30024
0.83
16.66
4.0
4.6
kg/l
1.0
1.0
1.37
417
4661
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3849
42285
0.85
16.21
1.9
2.1
u/l
165.5
166.1
0.01
3552
39344
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
708
4965
1.41
16.11
1.6
1.4
pmol/l
141.6
163.4
0.71
691
4847
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
13212
132411
0.83
15.48
4.5
4.7
mmol/l
5.9
5.9
0.22
11836
120609
(3023199) Leukocytes [#/volume] in Pleural fluid
220
1187
1.82
15.45
1.4
1.4
e6/l
4174.1
3018.9
0.16
163
853
(3048689) Calprotectin [Mass/mass] in Stool
1478
17682
0.80
15.11
2.0
2.0
ug/g
120.5
124.2
0.15
1112
13595
(3009508) Creatinine [Moles/volume] in Urine
3694
40534
0.85
15.08
2.8
3.0
mmol/l
6.4
6.4
0.59
2985
33733
(3022096) Basophils/100 leukocytes in Blood
6785
61044
1.14
14.89
4.9
6.2
%
0.7
0.7
0.83
6322
56495
(3018010) Neutrophils/100 leukocytes in Blood
7060
63763
1.14
14.48
4.9
6.0
%
57.2
56.7
1.90
6590
59197
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
45
120
3.66
14.24
1.4
3.0
mg/l
1.4
1.3
0.07
25
88
(3028308) Erythrocytes [#/volume] in Pleural fluid
199
1070
1.82
14.18
1.4
1.4
e6/l
29199.6
46533.8
0.77
117
602
(3031040) Bacteria [#/volume] in Urine by Automated count
9933
91887
1.14
13.86
4.8
4.9
e6/l
1014.6
2357.2
1.50
108
1088
(3007461) Platelets [#/volume] in Blood
15291
146814
1.40
13.72
27.7
20.5
e9/l
258.8
262.8
13.12
15078
142667
(3026493) Urate [Moles/volume] in Serum or Plasma
3048
33741
0.85
13.63
2.1
2.4
umol/l
4784.0
4619.8
0.07
2565
28755
(3035941) MCH [Entitic mass]
15291
146880
1.39
13.02
27.5
20.4
pg
30.4
30.2
37.66
15190
144589
(3024731) MCV [Entitic volume]
15291
146892
1.38
12.89
27.6
20.4
fl
91.9
91.1
82.86
15190
144605
(3008898) HLA-B27 [Presence]
296
4458
0.64
12.85
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
15291
146903
1.38
12.78
27.6
20.5
e12/l
4.3
4.4
130.61
15061
142277
(3010813) Leukocytes [#/volume] in Blood
15292
146916
1.38
12.76
27.7
20.5
e9/l
6.2
6.6
11.35
15060
142307
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
270
4126
0.63
12.53
1.6
1.6
iu/ml
0.1
8.6
1.05
65
891
(3000963) Hemoglobin [Mass/volume] in Blood
15291
146932
1.38
12.48
27.8
20.6
g/l
129.9
132.1
102.16
15192
144681
(3045788) Cell count panel - Pleural fluid
171
919
1.82
12.28
1.5
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
986
7582
1.28
12.11
1.6
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
812
10182
0.76
12.10
2.7
2.9
g/l
10.3
10.3
0.00
733
9298
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
206
1175
1.72
12.07
1.3
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1352
10815
1.24
11.85
3.7
2.6
ml/min/173m2
67.1
63.9
2.81
564
4366
(3013139) Helicobacter pylori Ag [Presence] in Stool
876
10847
0.77
11.84
1.2
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
120
581
2.02
11.79
1.2
1.4
umol/l
4.9
3.6
3.32
111
526
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
217
1271
1.67
11.55
1.3
1.6
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
159
855
1.82
11.43
1.3
1.3
u/l
431.6
364.3
0.23
151
805
(3017181) Myelocytes/100 leukocytes in Blood
1405
11337
1.23
11.33
2.9
4.2
%
1.9
0.9
15.80
548
2897
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
250
1529
1.60
11.22
1.4
1.5
—
—
—
0
0
(4281824)
343
2251
1.49
11.21
1.1
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
488
6509
0.72
11.12
1.2
1.3
u/ml
1.1
1.0
0.05
41
612
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2387
20268
1.17
11.00
2.6
2.7
e6/l
3.8
4.8
2.71
1190
10513
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
617
4534
1.34
10.58
1.9
1.9
ug/l
2.0
2.4
0.31
531
3959
(3036782) Glucose [Moles/volume] in Pleural fluid
162
900
1.76
10.49
1.3
1.3
mmol/l
6.3
6.5
0.55
151
841
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5594
58600
0.89
10.31
2.6
2.8
ug/l
137.9
106.4
9.64
5130
53887
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
184
1068
1.69
10.19
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
184
1068
1.69
10.19
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
184
1068
1.69
10.19
1.3
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
4349
38701
1.13
10.19
2.9
3.1
e6/l
83.5
64.9
0.32
3220
28922
(3051611) Lipemic interference index of Serum or Plasma
239
1491
1.57
9.92
2.6
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
2885
25034
1.15
9.87
2.6
2.7
mosm/kgh2o
504.6
504.3
0.02
2463
21037
(36304419) Bacteria [Presence] in Urine
3971
35207
1.13
9.80
2.7
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
4053
35987
1.13
9.76
2.8
3.0
e6/l
0.5
0.4
1.29
2966
26665
(3026008) Bacteria identified in Urine by Culture
5387
48741
1.12
9.29
3.3
3.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1431
11797
1.20
9.24
2.5
3.3
ng/l
72.1
82.6
7.73
1237
9952
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
123
655
1.84
9.22
1.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
123
655
1.84
9.22
1.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
123
655
1.84
9.22
1.3
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
4949
51971
0.89
9.20
4.0
4.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
123
657
1.83
9.14
1.3
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
11312
113700
0.89
9.12
4.4
4.6
pmol/l
14.9
14.9
0.41
10164
103767
(3009542) Hematocrit [Volume Fraction] of Blood
12550
118916
1.13
9.10
19.2
15.1
%
38.7
38.9
2.08
8903
83090
(40768441) Liver Pathology biopsy report
167
981
1.67
8.91
1.1
1.3
—
—
—
0
0
(4034850)
352
4758
0.71
8.77
11.6
9.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
156
908
1.68
8.63
1.5
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
735
8946
0.79
8.63
1.3
1.3
u/ml
187.3
176.5
0.17
670
8230
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2988
32205
0.88
8.52
1.2
1.3
u/ml
1.3
1.5
0.37
694
8485
(3024891) Influenza virus A+B Ag [Presence] in Specimen
423
3046
1.36
8.38
1.1
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
5062
45862
1.11
8.27
2.9
3.2
—
0.1
—
0
6
(40761535) Cells panel - Urine sediment
976
11454
0.82
8.17
3.3
3.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
652
5025
1.28
7.95
2.6
3.3
u/ml
1237.1
1156.8
0.04
530
4221
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
13014
129494
0.88
7.93
5.3
5.5
mu/l
2.1
2.0
0.10
11793
118991
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
353
2492
1.39
7.92
1.4
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
199
1258
1.55
7.90
1.5
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
365
4820
0.73
7.90
1.7
1.8
—
—
—
0
0
(4010399)
908
10695
0.82
7.88
1.4
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1306
10835
1.19
7.86
3.0
4.2
%
0.3
0.1
7.34
496
2680
(3028026) IgM [Mass/volume] in Serum or Plasma
652
7954
0.79
7.83
1.8
1.8
g/l
1.3
1.3
0.32
580
7203
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1237
10221
1.19
7.80
1.5
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
191
1207
1.55
7.61
1.2
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
251
1683
1.46
7.53
1.5
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
173
1073
1.58
7.49
1.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
830
9802
0.82
7.40
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
708
8486
0.80
7.28
1.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
827
6620
1.23
7.25
1.3
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
338
4446
0.73
7.16
1.5
1.7
g/l
0.2
0.2
1.31
312
4196
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3126
33295
0.89
7.12
2.2
2.3
mg/l
3.0
3.0
0.41
2655
28426
(3007164) IgA [Mass/volume] in Serum or Plasma
2517
27139
0.89
7.07
1.4
1.4
g/l
2.2
2.3
0.79
1244
15646
(3035350) Ketones [Presence] in Urine by Test strip
6646
68166
0.91
7.06
3.7
4.1
estimate
0.0
0.0
0.88
1336
12153
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
96
517
1.81
7.06
1.4
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
96
517
1.81
7.06
1.4
1.8
—
—
—
0
0
(3010421) pH of Blood
427
3169
1.32
6.98
3.2
3.3
ph
7.4
7.4
1.31
345
2631
(3000919) Neutrophils/100 leukocytes in Pleural fluid
57
258
2.16
6.87
1.4
1.4
%
9.6
20.3
4.01
50
236
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
352
4568
0.74
6.83
1.5
1.7
g/l
1.2
1.2
0.67
325
4334
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
620
7486
0.80
6.83
1.7
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3432
30715
1.11
6.83
1.6
1.7
mg/l
1.2
1.1
0.72
2654
23640
(40761536) Microorganisms panel - Urine sediment
1334
11229
1.17
6.76
4.3
4.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
182
1170
1.52
6.76
1.6
1.8
ug/l
18.1
24.9
1.74
175
1145
(3002179) Metamyelocytes/100 leukocytes in Blood
1238
10358
1.18
6.76
2.9
4.0
%
1.3
0.6
10.58
369
2102
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
14
27
5.05
6.71
9.1
5.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
14
27
5.05
6.71
4.6
2.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
491
3738
1.29
6.67
1.8
2.0
%
95.4
94.6
0.30
437
3435
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
96
527
1.78
6.65
1.4
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
5119
46789
1.10
6.64
3.4
3.6
e6/l
103.8
116.7
0.59
3467
31747
(3020961) Endomysium IgA Ab [Titer] in Serum
551
6718
0.79
6.62
1.1
1.1
titre
390.0
196.4
—
7
154
(3024869) Neuronal Ab [Presence] in Serum
49
213
2.24
6.54
1.1
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
872
7095
1.21
6.52
4.5
6.2
mmol/l
25.2
25.1
0.19
860
7030
(3013707) Erythrocyte sedimentation rate by Westergren method
10439
104775
0.91
6.50
3.7
4.4
mm/h
14.1
13.1
8.32
9499
96868
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
617
7386
0.81
6.30
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
329
0.24
6.16
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5688
58502
0.92
6.13
1.9
2.0
pmol/l
99.5
99.4
0.03
2643
27305
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
158
2303
0.66
6.10
2.3
1.7
nmol/l
0.9
0.8
0.71
133
1900
(3035880) pH of Pleural fluid
94
528
1.74
6.06
1.3
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
3187
33645
0.90
6.01
3.4
4.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
7504
69986
1.08
5.88
4.9
6.1
e9/l
0.2
0.2
12.74
6456
61292
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
373
2790
1.31
5.84
2.8
3.2
u/ml
162.2
841.3
2.59
343
2522
(3001893) Eosinophils/100 leukocytes in Pleural fluid
58
283
2.00
5.81
1.4
1.3
%
1.2
3.1
2.10
49
234
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
112
668
1.64
5.80
1.3
1.3
u/l
12.1
11.7
0.09
103
605
(3021601) Nitrite [Presence] in Urine by Test strip
6742
68741
0.92
5.77
5.0
5.4
estimate
0.0
0.0
3.28
1339
12238
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
66
340
1.89
5.66
1.4
1.4
%
72.6
62.4
2.01
57
277
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
369
4629
0.77
5.66
1.2
1.3
u/ml
9.1
43.2
7.91
15
308
(3013727) Leukocytes other/100 leukocytes in Blood
72
382
1.84
5.64
1.8
3.8
%
50.2
52.6
0.32
67
373
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2852
30194
0.90
5.64
1.6
1.7
pmol/l
35658013.7
34530936.9
0.03
2266
24642
(3009261) Glucose [Presence] in Urine by Test strip
6817
69423
0.92
5.59
3.8
4.1
estimate
0.0
0.0
0.06
1352
12304
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
447
3444
1.27
5.59
2.0
2.4
g/l
3.5
3.6
0.50
433
3272
(3039443) Prostate specific Ag panel - Serum or Plasma
26
90
2.82
5.58
1.8
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
470
5712
0.80
5.55
1.6
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
199
1362
1.43
5.48
2.2
3.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
136
865
1.54
5.41
1.4
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
357
2690
1.30
5.33
3.5
3.4
mmol/l
2.5
2.7
0.91
256
1924
(3013290) Carbon dioxide [Partial pressure] in Blood
357
2691
1.30
5.32
3.5
3.4
kpa
5.0
5.1
0.88
344
2632
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
877
7290
1.18
5.23
1.4
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
947
10703
0.85
5.23
2.0
2.3
ug/l
3.7
5.8
10.77
781
9097
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
337
4225
0.77
5.18
1.2
1.3
u/ml
6.0
7.0
0.12
50
736
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
875
9941
0.85
5.16
2.3
2.4
au/ml
26.8
28.2
0.09
46
531
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
359
4462
0.78
5.15
1.4
1.6
titre
77.7
269.4
5.92
13
226
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
23
78
2.88
5.14
1.6
1.3
pmol/l
64.8
27.1
0.99
12
28
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
23
78
2.88
5.14
1.0
1.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
476
5724
0.80
5.14
1.4
1.5
u/ml
24.3
15.7
0.34
11
139
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
332
4165
0.77
5.13
1.2
1.3
u/ml
5.7
5.8
0.01
26
473
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
70
381
1.79
5.09
6.5
2.8
ng/l
90.1
120.6
0.40
35
113
(3017354) Segmented neutrophils/100 leukocytes in Blood
184
1262
1.43
5.05
2.1
3.3
%
56.8
58.6
0.41
108
833
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
448
3505
1.25
4.97
2.5
2.2
%
193.9
190.8
0.30
430
3286
(3027315) Oxygen [Partial pressure] in Blood
357
2718
1.29
4.96
3.5
3.5
kpa
8.7
8.6
0.41
344
2659
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
34
144
2.30
4.90
1.3
1.3
%
10.6
14.9
0.59
21
67
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
505
6000
0.81
4.88
1.5
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
272
3478
0.76
4.88
1.2
1.2
u/ml
25.6
47.3
2.93
27
403
(3019198) Lymphocytes [#/volume] in Blood
7386
69151
1.08
4.87
4.9
6.0
e9/l
1.7
1.9
29.63
6370
60740
(3025468) Yersinia sp identified in Specimen by Organism specific culture
257
1877
1.34
4.84
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
621
7221
0.83
4.81
4.0
3.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
51
256
1.94
4.78
1.2
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
217
2848
0.74
4.68
1.4
1.5
e6/l
840.7
3277.0
1.10
161
2328
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
256
1879
1.33
4.67
1.3
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
217
2845
0.74
4.65
1.3
1.4
e6/l
12.7
40.1
2.71
149
2205
(3024522) Salmonella sp identified in Specimen by Organism specific culture
258
1898
1.33
4.64
1.3
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
101
624
1.58
4.63
1.6
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
34
691
0.48
4.62
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
324
4019
0.78
4.62
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
256
1883
1.33
4.61
1.3
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
262
1934
1.32
4.61
1.8
1.8
mmol/l
1.8
1.7
0.83
257
1887
(3042733) HLA Ab [Presence] in Serum
9
294
0.30
4.59
4.0
4.9
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
37
168
2.15
4.55
1.0
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
21
510
0.40
4.53
2.6
3.0
umol/l
27.0
28.2
0.18
16
383
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
97
1462
0.64
4.52
1.1
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
102
636
1.57
4.50
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
172
2324
0.72
4.49
1.3
1.2
—
—
—
0
0
(4038314)
8
8
9.75
4.44
1.5
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
2494
26288
0.91
4.42
1.7
1.8
nmol/l
1164.6
1197.0
0.93
1792
19639
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
256
1896
1.32
4.42
1.3
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
290
3624
0.78
4.41
1.4
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
333
2557
1.27
4.38
2.3
2.4
%
15.9
16.0
0.09
151
1281
(40768443) Skin Pathology biopsy report
786
6583
1.17
4.34
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
67
1087
0.60
4.31
1.3
1.2
titre
210.9
188.4
0.07
11
186
(3000492) Spirometry study
1114
12261
0.88
4.30
1.5
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
804
9048
0.86
4.25
1.2
1.3
au/ml
54.8
50.2
0.17
34
381
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
42
772
0.53
4.24
1.1
1.1
u/ml
2.1
6.3
—
7
105
(3015736) pH of Urine
5192
53031
0.93
4.22
3.4
3.8
ph
5.6
5.9
—
8
15
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
35
161
2.12
4.19
1.0
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
47
241
1.90
4.19
1.3
1.3
ug/l
619.2
217.0
0.53
37
142
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
90
557
1.58
4.14
1.1
1.1
%
100.4
95.1
1.15
74
425
(3003338) MCHC [Mass/volume]
11133
110753
0.93
4.12
24.2
18.1
g/l
330.1
330.4
4.62
11080
109991
(3024980) IgG subclass 4 [Mass/volume] in Serum
163
2187
0.72
4.11
1.3
1.5
g/l
0.6
0.6
0.43
115
1653
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
259
1947
1.30
4.05
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
575
4729
1.19
3.97
1.8
1.8
s
22.0
21.4
0.75
490
4089
(44806118)
176
1254
1.37
3.97
1.2
1.5
—
—
—
0
0
(44790048)
176
1254
1.37
3.97
1.2
1.5
—
—
—
0
0
(44790047)
176
1254
1.37
3.97
1.2
1.5
—
—
—
0
0
(44790049)
176
1254
1.37
3.97
1.2
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
276
2103
1.28
3.91
1.4
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
281
3464
0.79
3.87
1.2
1.2
u/ml
1.0
5.1
2.89
14
279
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
108
709
1.49
3.83
1.6
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
89
1311
0.66
3.79
1.5
1.5
%
33.2
34.0
0.07
50
767
(3006315) Basophils [#/volume] in Blood
7206
67778
1.07
3.78
4.8
5.9
e9/l
0.0
0.0
3.86
6127
58378
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
209
1546
1.32
3.71
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
289
3529
0.79
3.69
2.3
2.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
288
3515
0.79
3.67
1.6
1.7
e6/l
16901.6
11101.5
0.93
205
2559
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
211
2674
0.77
3.65
1.9
2.3
ug/min
60.7
71.2
0.20
106
1449
(3001604) Monocytes [#/volume] in Blood
7168
67464
1.06
3.63
4.8
5.9
e9/l
0.5
0.6
4.27
6094
58138
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
51
282
1.76
3.63
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
188
2418
0.75
3.63
1.5
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1098
11956
0.89
3.60
1.5
1.6
%
1.4
1.4
0.08
947
10382
(3029937) Albumin [Presence] in Urine by Test strip
3561
36688
0.93
3.57
4.1
4.6
estimate
0.0
0.0
3.41
1333
12227
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1213
13122
0.89
3.56
2.1
2.1
nmol/l
385.6
377.5
0.65
1105
11976
(3001964) Herpes simplex virus Ag [Presence] in Specimen
64
380
1.64
3.54
1.1
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
443
0.44
3.53
1.7
1.7
ug/l
8.9
8.7
0.09
20
443
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
134
1802
0.72
3.49
1.5
1.6
%
54.3
54.1
0.02
86
1108
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
163
2121
0.75
3.44
1.3
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
135
1806
0.73
3.42
1.2
1.2
u/l
28.5
34.2
0.41
111
1571
(3016879) Cocaine [Presence] in Urine
176
2256
0.76
3.35
1.5
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1174
10300
1.12
3.33
3.1
4.2
%
0.6
0.3
0.49
402
2306
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
336
3975
0.82
3.24
1.1
1.1
u/ml
2.0
8.1
5.48
43
420
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
123
1654
0.72
3.24
1.1
1.1
iu/ml
54.7
7286.2
0.57
34
339
(40768797) Stomach Pathology biopsy report
2004
21033
0.92
3.20
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
145
1892
0.74
3.15
1.5
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
105
716
1.43
3.14
3.1
2.4
ug/l
1.2
0.8
0.43
55
371
(3029612) Listeria sp Ab [Titer] in Serum
7
11
6.20
3.12
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
232
1786
1.27
3.11
1.1
1.1
%
125.8
124.3
0.30
213
1588
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
111
766
1.41
3.11
1.1
1.1
ratio
1.0
1.1
2.20
66
264
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
51
808
0.61
3.10
2.1
2.4
e9/l
0.2
0.2
0.03
46
709
(3039162) Centromere protein B Ab [Units/volume] in Serum
167
2129
0.76
3.09
1.2
1.3
u/ml
75.0
58.9
—
8
168
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
106
1446
0.71
3.07
1.1
1.1
—
1.6
—
0
27
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
232
1793
1.26
3.02
1.4
1.4
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
15
55
2.66
2.99
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
292
3471
0.82
2.99
1.3
1.3
miu/ml
247.9
220.2
0.66
144
1631
(3028300) Cannabinoids [Presence] in Urine
199
2467
0.78
2.97
1.5
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
180
1351
1.30
2.96
4.6
3.6
ug/l
1.7
2.1
0.69
140
1030
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
445
5085
0.85
2.96
1.6
1.6
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
41
677
0.59
2.96
1.1
1.0
u/ml
0.5
1.0
—
8
157
(3027135) IgG subclass 1 [Mass/volume] in Serum
105
1420
0.72
2.91
1.2
1.4
g/l
6.6
6.7
0.16
66
1002
(3027008) Opiates [Presence] in Urine
199
2459
0.79
2.90
1.5
1.7
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
105
1419
0.72
2.90
1.2
1.4
g/l
2.7
2.8
0.27
66
999
(3024139) IgG subclass 3 [Mass/volume] in Serum
105
1419
0.72
2.90
1.2
1.4
g/l
0.4
0.4
0.12
66
1001
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
217
1674
1.27
2.89
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2459
22492
1.08
2.85
2.4
2.6
e6/l
2.7
1.4
0.55
1256
12624
(3021788) Differential panel - Synovial fluid
218
2658
0.80
2.84
1.4
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
44
701
0.61
2.77
1.1
1.0
u/ml
0.4
1.4
1.07
12
204
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
81
1135
0.69
2.77
1.3
1.3
u/ml
3.9
1.1
0.43
27
533
(1761868) Lipid panel - Serum or Plasma
4449
45171
0.94
2.75
2.7
2.9
—
—
—
0
0
(4062490)
106
1415
0.73
2.73
1.2
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
311
3634
0.83
2.70
1.2
1.5
iu/ml
9.5
20.0
—
7
99
(3000764) Benzodiazepines [Presence] in Urine
200
2446
0.79
2.70
1.5
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
54
332
1.59
2.68
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
740
8093
0.89
2.68
2.4
2.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
61
895
0.66
2.67
1.7
2.3
ml
675.6
636.3
0.32
37
619
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
188
2310
0.79
2.65
1.4
1.3
nmol/l
0.2
0.2
—
9
148
(3000570) Elastase.pancreatic [Mass/mass] in Stool
395
4511
0.85
2.65
1.4
1.4
ug/g
280.9
281.7
0.03
242
2572
(3000850) Epithelial cells [#/volume] in Urine
2932
27059
1.07
2.64
2.3
2.5
e6/l
7.8
7.4
0.46
2541
23424
(3010144) Erythrocytes [#/volume] in Synovial fluid
98
1313
0.73
2.60
1.3
1.5
e6/l
209942.7
107165.8
0.62
64
890
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
110
1447
0.74
2.60
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
157
1966
0.78
2.59
1.3
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
337
3891
0.84
2.58
1.2
1.2
titre
598.7
982.9
1.14
15
171
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
978
10503
0.90
2.58
1.2
1.2
iu/ml
163.1
148.4
0.53
389
4072
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
57
841
0.66
2.58
1.6
1.5
u/l
5.9
5.5
0.24
46
705
(3022621) pH of Urine by Test strip
893
9636
0.90
2.58
3.4
3.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
206
0.38
2.52
2.1
1.9
umol/l
13.5
17.7
—
8
206
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3755
38209
0.94
2.47
1.6
1.7
mmol/l
1.4
1.3
0.91
3088
31890
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
85
1153
0.72
2.46
1.2
1.2
titre
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
160
1982
0.78
2.45
1.1
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
190
2307
0.80
2.45
1.4
1.3
nmol/l
5.0
1.3
0.39
184
2215
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
58
841
0.67
2.43
2.0
2.3
e6/l
490.3
535.7
0.23
47
712
(3033799) Differential panel - Peritoneal fluid
56
357
1.53
2.42
1.2
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
448
3783
1.16
2.39
2.6
2.8
u/ml
0.4
0.4
0.87
270
2193
(3016750) Collection duration of Urine
44
673
0.64
2.38
1.6
2.2
min
526.1
499.9
0.87
28
512
(4094501)
324
3723
0.84
2.38
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1369
14408
0.92
2.37
1.6
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
433
4858
0.86
2.35
1.6
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
320
3675
0.85
2.34
1.8
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
104
1354
0.75
2.33
1.2
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
15
310
0.47
2.32
1.3
2.0
e6/l
3608.3
202.4
—
6
177
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
94
668
1.37
2.32
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
94
668
1.37
2.32
1.2
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
276
3206
0.84
2.30
1.3
1.3
mg/l
573.6
533.8
0.33
262
3051
(3004716) Salmonella sp identified in Stool by Organism specific culture
636
6947
0.89
2.30
1.4
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
133
1670
0.77
2.29
5.3
5.1
umol/l
362.5
373.9
0.40
113
1453
(3048929) Epstein Barr virus Ab [Presence] in Serum
254
2971
0.83
2.29
1.1
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
86
1149
0.73
2.29
1.6
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
3503
35628
0.95
2.25
3.7
3.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
59
837
0.69
2.23
2.1
2.1
ug/l
4.2
4.0
0.05
52
743
(3025577) Chromium [Mass/volume] in Blood
57
813
0.68
2.22
2.0
2.1
ug/l
3.0
2.8
0.12
47
693
(3020630) Protein [Mass/volume] in Serum or Plasma
1209
10863
1.09
2.22
2.7
2.6
g/l
66.4
66.4
0.06
1078
9724
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
160
1955
0.80
2.21
1.1
1.2
u/ml
257.9
294.5
0.79
96
1236
(3024932) HLA-DR beta [Type]
16
317
0.49
2.21
1.4
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
64
429
1.46
2.20
1.0
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
85
601
1.38
2.18
1.1
1.1
u/ml
48.7
10.1
—
7
55
(46235355) HIV 1 and 2 tests - Meaningful Use set
1563
16289
0.93
2.14
1.7
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
17
325
0.51
2.12
1.1
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
32
510
0.61
2.11
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
149
1823
0.79
2.10
1.1
1.1
u/ml
1.5
0.9
0.26
55
673
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
145
1114
1.27
2.10
2.3
2.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
59
826
0.69
2.10
1.9
2.5
e6/l
528.4
841.1
1.50
28
368
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
176
2113
0.81
2.10
1.3
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
156
1897
0.80
2.09
1.1
1.1
u/ml
3.1
3.5
0.25
69
837
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
59
394
1.46
2.09
1.2
1.7
e6/l
2690.7
15338.3
1.37
33
186
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
119
894
1.30
2.06
1.3
1.4
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
17
80
2.07
2.04
1.1
1.8
%
67.7
62.9
0.23
12
50
(3023183) Ammonium ion [Moles/volume] in Plasma
260
2132
1.19
2.04
2.0
2.6
umol/l
37.9
32.9
1.78
209
1807
(4027681)
49
705
0.68
2.03
1.4
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
20
357
0.55
2.02
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
20
357
0.55
2.02
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
20
357
0.55
2.02
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
20
357
0.55
2.02
1.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
19
344
0.54
2.01
1.1
1.0
u/ml
0.5
0.7
—
10
173
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
174
2078
0.81
1.99
1.1
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
245
2829
0.84
1.97
1.2
1.2
mmol/l
3.6
3.7
1.30
230
2661
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
168
2009
0.81
1.95
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
46
662
0.68
1.93
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
25
138
1.77
1.92
1.4
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
129
990
1.27
1.92
3.9
3.5
%
22.6
22.1
0.11
50
363
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
79
566
1.36
1.91
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
435
4797
0.88
1.90
1.1
1.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
64
444
1.41
1.88
1.3
1.9
e6/l
1017.8
2869.0
0.81
41
281
(3007566) Smooth muscle Ab [Titer] in Serum
344
3848
0.87
1.86
1.2
1.2
titre
109.0
149.7
0.41
30
310
(3011335) Digoxin [Mass/volume] in Serum or Plasma
20
104
1.87
1.86
2.7
2.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
75
536
1.36
1.85
2.4
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
341
2887
1.15
1.84
2.1
2.5
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
12
51
2.29
1.84
1.2
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
49
325
1.47
1.83
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
119
911
1.27
1.82
1.3
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
35
525
0.65
1.81
1.1
1.1
miu/ml
1091.4
1553.5
2.26
35
525
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1734
17889
0.94
1.80
7.0
6.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1413
12897
1.07
1.80
2.2
2.4
u/l
47.6
38.8
0.62
1209
10885
(3011288) Drugs identified in Urine by Screen method
138
1666
0.81
1.78
2.1
2.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
127
1.77
1.78
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
178
1430
1.21
1.78
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
61
425
1.40
1.77
1.0
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
43
280
1.50
1.76
1.2
1.1
pmol/l
2.6
2.9
—
5
36
(3050794) Legionella sp Ab [Presence] in Serum
19
99
1.87
1.76
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
23
376
0.60
1.73
1.4
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1166
10586
1.08
1.72
4.6
6.1
mmol/l
1.3
1.3
0.12
1129
10256
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
188
0.47
1.72
16.4
8.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
543
5867
0.90
1.71
1.9
2.0
u/l
41.7
40.2
1.02
485
5177
(3020356) Listeria sp identified in Specimen by Organism specific culture
12
53
2.21
1.70
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
43
609
0.69
1.70
1.3
1.3
nmol/l
128.7
134.3
0.50
43
609
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
29
174
1.62
1.69
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
159
1879
0.82
1.69
1.2
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
74
958
0.75
1.69
1.1
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
69
902
0.74
1.69
1.2
1.1
mg/l
318.8
253.7
0.54
63
787
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
72
934
0.75
1.67
1.3
1.1
mg/l
45.3
40.0
0.19
63
781
(3002621) Streptococcal DNAse B [Units/volume] in Serum
17
87
1.90
1.67
1.1
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
80
1022
0.76
1.67
1.1
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1065
11143
0.93
1.67
2.4
2.8
ng/l
161.2
176.7
0.86
971
10207
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
106
1304
0.79
1.65
1.2
1.1
—
36.7
—
0
13
(3044007) Cell count panel - Peritoneal fluid
52
358
1.42
1.63
1.3
1.9
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
15
74
1.98
1.63
1.1
1.1
s
34.8
36.5
0.67
15
61
(3022145) Colonoscopy Study observation
1564
16130
0.94
1.63
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4389
44073
0.96
1.63
2.3
2.5
u/l
57.0
58.1
0.55
4023
40248
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
96
1193
0.78
1.63
1.0
1.0
u/ml
0.1
0.5
1.92
21
233
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
74
951
0.76
1.62
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
625
6682
0.91
1.62
1.6
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
45
624
0.70
1.60
2.0
2.8
%
41.1
41.8
0.05
14
218
(4306422)
224
1860
1.18
1.60
1.1
1.2
—
—
—
0
0
(4015189)
24
379
0.62
1.59
1.9
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
280
3133
0.87
1.57
3.2
3.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
55
2.13
1.57
1.4
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
49
667
0.71
1.57
1.0
1.1
u/l
1.0
1.1
1.12
26
314
(3037756) Immunofixation for Serum or Plasma
245
2767
0.86
1.57
1.8
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
142
1681
0.82
1.56
1.1
1.1
u/ml
0.9
1.4
0.56
35
356
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
74
545
1.32
1.55
1.1
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
170
1382
1.20
1.55
1.4
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
41
273
1.46
1.54
1.2
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
189
1552
1.19
1.54
3.5
3.1
nmol/l
4.6
8.8
0.59
183
1496
(3042631) Mycobacterium sp identified in Specimen
202
1669
1.18
1.54
2.2
2.7
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
11
49
2.19
1.54
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
299
2547
1.15
1.54
3.2
3.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
53
709
0.73
1.53
1.4
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
161
1305
1.20
1.52
1.1
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
168
1951
0.84
1.52
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
135
1600
0.82
1.51
2.4
2.7
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
139
0.42
1.51
1.7
1.1
—
—
—
0
0
(4198724)
18
301
0.58
1.51
1.1
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
170
1386
1.20
1.51
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
170
1386
1.20
1.51
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
372
3220
1.13
1.50
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
170
1387
1.20
1.50
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
90
1114
0.79
1.50
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
195
2231
0.85
1.49
1.4
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
15
77
1.90
1.48
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
15
77
1.90
1.48
1.0
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
1062
9673
1.07
1.48
3.2
2.9
e9/l
3.8
4.0
0.62
849
7234
(3023430) Cat dander IgE Ab [Units/volume] in Serum
115
1381
0.81
1.47
1.1
1.1
u/ml
1.8
3.5
1.90
42
512
(3014133) Dog dander IgE Ab [Units/volume] in Serum
124
1477
0.82
1.47
1.0
1.1
u/ml
2.5
3.7
0.78
43
506
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
8
164
0.47
1.46
1.4
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
49
657
0.73
1.45
1.5
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
8
166
0.47
1.45
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
892
8078
1.08
1.45
1.4
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
11
210
0.51
1.45
1.7
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
131
1050
1.22
1.41
5.7
6.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
8073
79964
0.97
1.39
2.6
2.8
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
28
412
0.66
1.39
1.4
1.5
%
44.7
51.1
0.34
20
349
(40758292) HTLV I+II Ab panel - Serum
9
173
0.51
1.39
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
189
2153
0.85
1.39
1.2
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
308
2651
1.13
1.39
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
224
1886
1.16
1.38
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
186
2120
0.85
1.38
1.1
1.1
u/ml
1.4
1.1
0.20
72
731
(3044242) Glucose [Moles/volume] in Arterial blood
73
549
1.30
1.36
2.0
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
8903
85426
1.03
1.36
3.0
3.0
u/l
53.9
43.8
11.18
8231
78843
(40761539) Cells [Type] in Urine sediment by Light microscopy
45
314
1.40
1.36
1.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
114
1351
0.82
1.32
1.2
1.2
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
40
0.00
1.31
0.0
1.0
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
37
251
1.44
1.31
1.1
1.4
g/l
29.3
28.6
0.09
30
194
(43055514) Macroprolactin [Presence] in Serum or Plasma
30
195
1.50
1.30
1.6
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
38
520
0.71
1.30
9.2
11.5
nmol/l
694.2
2765.3
0.55
38
499
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
42
292
1.40
1.30
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
76
940
0.79
1.30
1.1
1.0
ng/l
38.7
46.0
0.96
58
653
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
68
852
0.78
1.29
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
55
709
0.75
1.29
1.2
1.5
%
2.5
3.8
0.74
12
138
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
179
1492
1.17
1.28
1.4
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
150
1727
0.84
1.28
1.2
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
373
4034
0.90
1.27
2.9
3.4
ratio
3.5
4.4
0.13
20
316
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
88
1066
0.80
1.27
2.4
2.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
76
936
0.79
1.26
1.1
1.0
ng/l
736.1
731.4
0.03
56
636
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
153
0.51
1.24
1.1
1.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
25
158
1.54
1.24
1.3
1.2
mmol/l
2.9
2.0
0.16
16
97
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
108
1276
0.82
1.23
1.2
1.1
—
90.0
—
0
17
(3045424) Erythrocytes [Presence] in Urine
287
2485
1.13
1.21
1.4
1.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
76
930
0.80
1.21
1.1
1.0
ng/l
325.9
379.9
0.56
59
655
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
26
167
1.52
1.21
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
515
4601
1.09
1.21
1.7
1.7
mg/l
2.5
3.3
2.68
407
3296
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
26
168
1.51
1.18
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
26
168
1.51
1.18
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
454
4040
1.10
1.17
2.1
2.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
57
425
1.31
1.17
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
107
1257
0.83
1.17
1.9
2.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
389
4170
0.91
1.15
2.9
3.4
mg/l
46.3
81.2
0.91
309
3400
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
443
3942
1.10
1.15
1.2
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
87
686
1.24
1.15
2.6
3.0
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
35
0.00
1.14
0.0
1.0
—
0.1
—
0
20
(3045414) Leukocytes [Presence] in Urine
649
6800
0.93
1.14
1.9
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
189
1601
1.15
1.13
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
189
1601
1.15
1.13
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
179
2007
0.87
1.12
1.6
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
172
1934
0.86
1.12
1.2
1.3
u/ml
116.5
118.8
0.17
41
464
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
5
20
2.44
1.11
1.0
1.1
%
2.2
2.0
—
5
20
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
347
3733
0.90
1.11
2.0
2.1
mg/l
10.2
11.2
1.64
319
3434
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
111
1292
0.84
1.11
1.2
1.1
—
6.8
—
0
10
(3036048) Francisella tularensis Ab [Titer] in Serum
16
250
0.62
1.09
1.1
1.2
—
778.8
—
0
17
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1456
14845
0.95
1.08
1.6
1.5
—
—
—
0
0
(4268621)
150
1254
1.17
1.08
2.3
2.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
111
1288
0.84
1.08
1.2
1.2
u/ml
118.4
64.4
—
5
62
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
31
421
0.72
1.06
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
493
5204
0.92
1.06
2.0
2.3
g/l
7.7
7.5
0.93
372
3821
(3011412) CD3 cells [#/volume] in Blood
102
1189
0.83
1.05
2.0
2.3
e9/l
1.3
1.1
0.69
65
719
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
37
487
0.74
1.05
1.9
2.3
umol/l
39.9
54.8
2.89
25
375
(21494815) CD4 cells/100 lymphocytes in Specimen
79
944
0.81
1.05
1.9
2.0
%
38.7
42.5
0.61
12
128
(3020876) Protein [Mass/time] in 24 hour Urine
84
997
0.82
1.05
1.6
2.0
g/24h
0.3
1.0
—
5
46
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
390
4154
0.91
1.04
2.9
3.4
mg/l
35.5
40.4
0.28
308
3384
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
492
5187
0.92
1.03
2.0
2.3
g/l
3.8
3.7
0.41
348
3643
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
191
2116
0.88
1.03
1.5
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
243
2652
0.89
1.03
1.2
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
493
5196
0.92
1.03
2.0
2.3
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
562
5892
0.93
1.03
2.8
3.2
mmol/l
25.8
25.5
1.43
552
5736
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
108
1249
0.84
1.03
1.2
1.2
u/ml
19.8
45.8
—
10
116
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
51
639
0.78
1.02
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
105
1217
0.84
1.02
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
105
1217
0.84
1.02
1.1
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
43
551
0.76
1.02
12.0
16.1
nmol/l
1253.1
6016.8
0.84
35
529
(3011985) Renin [Units/volume] in Plasma
181
2010
0.88
1.02
1.4
1.4
mu/l
50.7
50.1
0.01
160
1781
(40759836) Histone Ab [Presence] in Serum by Immunoblot
105
1215
0.84
1.01
1.1
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
42
538
0.76
1.00
2.4
1.9
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
29
393
0.72
1.00
1.1
1.1
umol/24h
0.5
0.6
2.14
12
186
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
108
1245
0.84
1.00
1.2
1.2
u/ml
107.3
66.3
—
7
76
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
34
241
1.38
1.00
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1673
15654
1.05
0.99
2.5
2.5
umol/l
8.6
7.4
1.22
1421
13319
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
152
1704
0.87
0.99
1.1
1.1
g/l
1.6
1.5
1.05
138
1519
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
221
1914
1.13
0.99
1.2
1.2
u/ml
2.7
3.9
0.82
65
631
(3051101) Glucose [Moles/volume] in Cord blood
15
231
0.63
0.98
4.9
5.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
106
1222
0.84
0.98
1.1
1.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
171
1457
1.14
0.98
5.3
6.3
mg/l
12.7
12.2
0.63
155
1329
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
27
369
0.71
0.98
1.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
42
309
1.32
0.98
1.4
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
26
176
1.44
0.98
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
58
710
0.79
0.98
1.7
1.7
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
28
0.00
0.98
0.0
1.0
—
0.2
—
0
10
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
85
999
0.83
0.98
1.5
1.3
nmol/l
1.6
1.5
0.42
79
896
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
106
1221
0.84
0.97
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
106
1221
0.84
0.97
1.1
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
49
612
0.78
0.97
1.2
1.3
%
54.0
60.6
—
8
73
(3020191) Ethanol [Moles/volume] in Serum or Plasma
59
720
0.80
0.97
1.2
1.4
promille
1.4
1.2
0.43
48
523
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
30
0.00
0.96
0.0
3.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
22
311
0.69
0.96
1.4
1.8
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
69
827
0.81
0.96
1.1
1.1
nmol/l
1.3
6.0
—
10
160
(3015183) Erythrocyte sedimentation rate
49
611
0.78
0.96
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
137
1544
0.86
0.96
1.4
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
389
4126
0.92
0.96
1.9
2.1
ug/l
315.4
486.3
1.21
351
3836
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
77
912
0.82
0.96
1.7
2.0
%
12.5
14.8
1.24
22
402
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
137
1.49
0.95
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
332
2948
1.10
0.95
1.6
1.7
mu/l
281.9
336.8
1.38
311
2634
(3000494) Fungus identified in Specimen by Culture
1707
16002
1.04
0.94
1.4
1.4
—
—
—
0
0
(4133840)
20
286
0.68
0.94
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
184
2027
0.88
0.94
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
150
1675
0.87
0.94
1.3
1.3
mmol/l
7.5
7.4
0.10
120
1213
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
103
1184
0.85
0.94
1.2
1.2
u/ml
1.9
9.9
—
5
94
(4146454)
131
1477
0.86
0.93
2.8
2.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
28
376
0.72
0.93
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
42
531
0.77
0.93
1.5
1.8
umol/l
224.8
129.9
0.45
24
293
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
41
520
0.77
0.93
1.2
1.2
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
8
141
0.55
0.93
1.1
1.5
—
129.9
—
0
7
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
342
3640
0.91
0.92
1.1
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
142
0.55
0.92
4.1
6.8
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
34
442
0.75
0.92
1.5
1.2
g/l
37.9
38.8
0.15
20
223
(1761482) Bacteria [#/volume] in Urine by Culture
327
3486
0.91
0.92
5.3
4.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
38
486
0.76
0.92
2.6
2.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
462
4852
0.93
0.91
1.9
2.3
g/l
9.8
10.0
0.42
371
3974
(3011897) Casein IgE Ab [Units/volume] in Serum
11
179
0.60
0.91
1.0
1.1
—
3.9
—
0
31
(3023520) Reticulocytes [#/volume] in Blood
996
10200
0.95
0.91
2.2
2.5
e9/l
71.0
71.0
0.01
741
7653
(44813793)
94
1085
0.84
0.90
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
93
1074
0.84
0.90
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5136
50958
0.97
0.90
3.2
3.5
ng/l
29.6
55.6
1.59
3611
33324
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
29
384
0.74
0.89
2.6
2.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
19
270
0.69
0.87
2.0
2.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
76
890
0.83
0.87
1.1
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
8
42
1.86
0.87
1.0
1.6
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
28
198
1.38
0.86
1.3
1.2
mmol/l
2.3
1.9
1.49
21
109
(3019060) Gas panel - Arterial blood
784
8061
0.94
0.85
4.1
4.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
17
109
1.52
0.84
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
370
3904
0.92
0.84
1.4
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
90
1033
0.85
0.83
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
895
9163
0.95
0.83
2.1
2.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
107
895
1.17
0.82
1.5
1.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
12
185
0.63
0.82
1.2
1.1
umol/24h
1.7
1.6
0.14
12
185
(3014576) Chloride [Moles/volume] in Serum or Plasma
1636
15379
1.04
0.81
5.1
6.3
mmol/l
104.3
104.1
1.17
1604
15057
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
43
329
1.27
0.80
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
256
2736
0.91
0.79
1.4
1.4
mmol/l
57.6
61.3
0.86
198
2167
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3009883) Potato IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
0.2
—
0
17
(3010838) Calcium [Moles/time] in 24 hour Urine
106
890
1.16
0.79
1.5
1.7
mmol/24h
5.8
5.4
0.13
11
67
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
58
689
0.82
0.79
1.8
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
3261
32501
0.97
0.79
1.5
1.5
nmol/l
21.6
21.9
0.39
2695
27322
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
55
435
1.23
0.78
1.2
1.1
%
97.6
94.2
0.26
28
184
(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.1
—
24.3
—
0
6
(3025130) Human papilloma virus identified in Specimen
270
2404
1.10
0.77
1.4
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
775
7171
1.06
0.77
2.6
3.4
kpa
5.2
5.2
0.09
703
6594
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
100
1129
0.86
0.77
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
40
305
1.28
0.77
1.5
1.7
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
81
929
0.85
0.76
1.7
2.0
%
71.7
73.2
0.38
76
888
(3034426) Prothrombin time (PT)
52
410
1.24
0.76
1.2
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
43
332
1.26
0.75
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
113
958
1.15
0.75
1.7
1.7
—
—
—
0
0
(3019977) pH of Arterial blood
78
642
1.18
0.75
2.7
2.8
ph
7.4
7.4
0.75
38
222
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
52
620
0.82
0.74
11.7
11.9
mmol/l
0.7
0.6
0.72
46
564
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
30
382
0.76
0.74
1.1
1.2
pmol/l
230.0
337.6
1.81
23
266
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
14
89
1.53
0.73
1.1
1.1
u/l
7.4
11.1
0.52
14
89
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
24
2.03
0.73
1.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
21
146
1.40
0.73
1.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
37
457
0.79
0.73
1.7
1.7
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
56
448
1.22
0.73
1.2
1.1
%
115.0
114.1
0.07
51
401
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
522
5400
0.94
0.72
1.5
1.7
g/l
1.7
1.6
0.96
427
4597
(3034274) Bile acid [Moles/volume] in Serum --fasting
128
1099
1.14
0.72
1.7
1.7
umol/l
5.3
7.6
0.82
95
784
(3020779) Urea [Moles/volume] in Serum or Plasma
961
9774
0.96
0.71
5.0
6.4
mmol/l
8.4
9.3
3.80
918
9273
(3000991) Gas panel - Venous blood
1065
9956
1.05
0.71
5.4
7.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
152
1320
1.12
0.71
1.1
1.1
%
97.7
94.7
0.69
145
1232
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
51
405
1.23
0.71
1.8
1.9
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
22
291
0.74
0.71
1.1
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
35
266
1.28
0.70
1.5
1.3
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
9
56
1.57
0.70
1.0
1.2
u/l
411.2
631.0
—
9
44
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1883
17811
1.03
0.69
4.4
4.7
%
33.3
33.4
0.20
1197
11778
(3008295) Osmolality of Serum or Plasma
127
1397
0.88
0.69
1.2
1.4
mosm/kgh2o
273.8
275.4
0.34
93
1071
(3027923) C peptide [Moles/volume] in Serum or Plasma
54
635
0.83
0.69
1.3
1.5
nmol/l
1.5
1.2
1.36
37
502
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1221
11460
1.04
0.69
5.6
7.1
g/l
118.4
118.6
0.17
1176
11052
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
38
293
1.26
0.69
1.2
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
41
1.66
0.68
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
37
285
1.27
0.68
1.1
1.1
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
13
83
1.53
0.68
1.1
1.1
mg/l
10.9
10.3
0.06
13
75
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
176
1548
1.11
0.67
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
60
488
1.20
0.67
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
22
288
0.74
0.67
1.2
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
94
1052
0.87
0.67
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
30
225
1.30
0.67
1.2
1.6
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
55
444
1.21
0.67
1.1
1.1
%
95.4
90.9
0.52
28
183
(3022217) INR in Platelet poor plasma by Coagulation assay
1778
16816
1.03
0.67
20.9
22.5
inr
1.3
1.3
0.16
258
2325
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
58
471
1.20
0.66
1.2
1.2
g/l
0.3
0.3
1.26
49
382
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
23
298
0.75
0.66
1.2
1.2
mg/l
0.8
22.7
0.71
14
224
(3034092) Cytoplasmic Ig cells/100 cells in Blood
11
162
0.66
0.64
12.4
9.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
5
28
1.74
0.64
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
72
817
0.86
0.63
1.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
128
0.61
0.63
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
393
4077
0.94
0.63
1.7
1.8
iu/l
26.9
14.1
0.24
148
1458
(3004119) Hemoglobin [Mass/volume] in Venous blood
717
7312
0.95
0.62
2.6
3.1
g/l
124.5
126.7
2.23
696
7159
(44806420)
30
371
0.79
0.62
2.0
2.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
547
5053
1.06
0.62
2.6
3.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
486
4475
1.06
0.62
2.6
3.7
mmol/l
25.2
25.2
0.05
435
4095
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
101
0.58
0.62
1.8
1.6
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
14
194
0.70
0.61
1.6
1.4
%
53.7
49.9
—
6
103
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
148
0.66
0.60
1.2
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
586
5429
1.05
0.60
2.8
3.8
mmol/l
24.6
24.5
0.41
518
4845
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
52
423
1.20
0.60
1.2
1.1
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
19
0.00
0.60
0.0
1.1
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1354
13613
0.97
0.60
2.0
2.4
%
1.9
1.8
1.84
1189
11959
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
69
576
1.17
0.60
1.2
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
69
576
1.17
0.60
1.2
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
66
549
1.17
0.60
1.2
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
21
0.00
0.60
0.0
6.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
122
1061
1.12
0.60
2.3
2.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
66
550
1.17
0.59
2.2
2.5
mmol/l
9.8
9.0
1.15
56
402
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2603
25905
0.97
0.59
3.2
3.6
ng/l
123.3
264.7
6.23
2000
19473
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
20
259
0.75
0.59
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
174
1856
0.91
0.58
1.3
1.3
pmol/l
342.3
299.8
0.23
139
1475
(3002619) Bacteria identified in Specimen by Culture
22
280
0.77
0.58
1.2
1.3
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
7
111
0.61
0.58
1.1
1.3
—
80.3
—
0
17
(3023410) Appearance of Cerebral spinal fluid
120
1304
0.90
0.57
1.4
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
369
3819
0.94
0.57
3.1
4.0
mmol/l
3.8
3.8
0.55
348
3607
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
560
5727
0.95
0.57
2.3
2.7
%
1.1
1.2
4.00
560
5692
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1034
10430
0.96
0.56
3.1
3.2
pmol/l
4.5
4.4
1.53
922
9144
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
478
4907
0.95
0.56
2.0
2.3
g/l
3.2
3.1
1.07
359
3720
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
201
2126
0.92
0.56
1.1
1.1
au/ml
5.8
13.8
—
7
78
(3028679) Herpes simplex virus Ab [Presence] in Serum
68
573
1.16
0.54
1.2
1.2
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
6
37
1.58
0.54
2.7
2.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
89
980
0.88
0.54
1.1
1.0
mg/l
316.4
610.0
0.46
77
858
(3040151) Glucose [Moles/volume] in Capillary blood
152
1348
1.10
0.54
4.3
6.5
mmol/l
7.1
7.5
0.94
127
1101
(3037467) Urinalysis macro (dipstick) panel - Urine
9785
94648
1.02
0.53
4.4
4.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
66
556
1.16
0.53
1.3
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
34
405
0.82
0.53
1.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
757
7087
1.04
0.53
2.6
3.4
ph
7.4
7.4
1.49
116
951
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
10
143
0.68
0.53
1.2
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
210
0.74
0.53
11.2
8.9
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
78
863
0.88
0.52
1.7
1.9
nmol/l
17.0
16.7
0.10
72
808
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
206
1857
1.08
0.51
1.2
1.2
u/ml
3.8
3.8
0.01
76
793
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
39
1.50
0.51
1.0
1.1
nmol/l
318.3
324.3
—
6
39
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
169
1512
1.09
0.51
4.6
4.7
u/ml
109.1
130.8
0.15
47
427
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
52
433
1.17
0.49
1.2
1.2
%
110.8
113.9
0.36
45
380
(3020891) Body temperature
491
5014
0.95
0.49
3.6
4.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
125
1105
1.10
0.49
1.8
1.7
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
45
1.52
0.48
1.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
17
125
1.33
0.46
1.0
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2008
19152
1.02
0.46
1.9
1.9
s
29.1
29.3
0.84
1951
18552
(36660697) Celiac disease serology panel - Serum
1168
11705
0.97
0.46
1.2
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
12
161
0.73
0.46
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
418
4276
0.95
0.46
1.2
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
15
194
0.75
0.46
2.8
2.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
73
803
0.89
0.46
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
347
3202
1.06
0.46
1.3
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
24
186
1.26
0.46
1.2
1.2
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
8
114
0.68
0.45
1.0
1.1
—
2.0
—
0
15
(3036312) Salmon IgE Ab [Units/volume] in Serum
5
81
0.60
0.45
1.0
1.0
u/ml
0.0
0.2
—
5
59
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
47
533
0.86
0.45
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1253
12536
0.97
0.45
1.5
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
727
6831
1.04
0.45
2.6
3.4
mmol/l
2.1
2.1
0.05
578
5241
(3045142) Bone marrow Pathology biopsy report
152
1364
1.09
0.45
1.2
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
796
8020
0.97
0.44
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
283
2922
0.94
0.44
1.4
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
424
4327
0.95
0.44
1.2
1.2
—
—
—
0
0
(4212803)
9
124
0.71
0.43
1.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
9
124
0.71
0.43
1.8
1.6
umol/l
38.9
49.8
—
9
124
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
40
331
1.18
0.43
1.3
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
128
0.68
0.43
1.1
2.3
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
90
0.65
0.42
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
73
797
0.89
0.42
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
424
4321
0.95
0.42
1.2
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1289
12246
1.03
0.42
5.4
6.8
%
96.0
95.8
0.39
1240
11791
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
555
5622
0.96
0.42
2.3
2.7
%
0.7
0.7
0.22
532
5382
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
645
6060
1.04
0.41
1.1
1.1
u/ml
1.2
1.6
—
8
101
(3030313) Adrenal Ab [Titer] in Serum
14
102
1.34
0.41
1.1
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
315
2912
1.05
0.41
2.6
2.8
mg/l
1.4
1.5
3.69
280
2646
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
130.6
—
0
16
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
163
1.26
0.41
1.3
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
15
111
1.32
0.40
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
267
2459
1.06
0.40
1.5
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
24
190
1.23
0.40
1.4
1.3
—
—
—
0
0
(4211845)
88
775
1.11
0.40
4.1
3.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
116
1231
0.92
0.40
2.6
2.9
mg/l
72.0
32.4
0.42
76
827
(3037121) Protein [Mass/volume] in Urine
443
4501
0.96
0.39
2.6
2.9
g/l
0.2
0.3
3.69
148
1501
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
190
1732
1.07
0.39
1.2
1.3
—
33.5
—
0
11
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
434
4411
0.96
0.39
2.1
2.5
g/l
0.7
0.8
0.37
362
3724
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
33
271
1.19
0.39
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
3049
29277
1.02
0.39
3.7
4.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
1466
13972
1.02
0.38
5.2
6.4
mmol/l
1.2
1.3
0.30
1205
11213
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
11
78
1.37
0.38
1.1
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
17
130
1.27
0.37
1.3
1.3
u/l
33.3
331.6
0.64
12
88
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
346
3529
0.95
0.37
2.0
2.3
g/l
0.0
0.0
0.00
308
3218
(3035637) Corticotropin [Mass/volume] in Plasma
177
1614
1.07
0.37
1.4
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
107
1134
0.92
0.37
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
282
0.83
0.36
1.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
64
696
0.90
0.36
1.1
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
351
3575
0.96
0.36
2.0
2.3
g/l
0.0
0.0
0.17
308
3229
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
81
869
0.91
0.36
1.7
2.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
22
260
0.82
0.36
2.0
2.3
ug/l
4.8
3.7
0.30
12
104
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
11
79
1.36
0.35
1.6
2.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
74
0.66
0.35
5.4
7.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
382
3567
1.04
0.35
2.5
2.3
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
5
76
0.64
0.35
1.0
2.5
umol/l
410.4
433.0
—
5
76
(3006184) Hemoglobin [Mass/volume] in Capillary blood
309
2872
1.05
0.35
2.0
2.1
g/l
125.6
126.7
0.37
211
2028
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
71
765
0.90
0.35
1.2
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
6
42
1.39
0.35
1.5
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
42
1.39
0.35
1.2
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
10
130
0.75
0.34
1.1
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
61
533
1.12
0.34
1.5
1.6
ug/l
0.4
0.4
0.64
45
346
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1443
13781
1.02
0.33
3.4
4.1
u/l
262.5
244.7
2.01
1359
12934
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
39
331
1.15
0.33
1.1
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1464
13987
1.02
0.33
5.2
6.4
kpa
5.2
5.1
0.88
1397
13358
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
27
222
1.19
0.33
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
81
720
1.10
0.33
1.1
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
87
0.67
0.33
1.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
16
124
1.26
0.33
1.1
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
79
702
1.10
0.32
1.5
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1463
13982
1.02
0.32
5.2
6.4
kpa
13.6
12.6
6.43
1396
13346
(3001019) Free T4 and TSH panel - Serum or Plasma
703
7044
0.97
0.32
1.7
1.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
241
2466
0.95
0.32
1.3
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
380
3847
0.96
0.31
2.1
2.3
g/l
0.0
0.0
0.86
336
3486
(3006462) Nitrate [Presence] in Urine
80
713
1.09
0.31
4.3
3.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
33
278
1.16
0.31
2.3
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
79
704
1.09
0.31
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
128
0.76
0.31
3.6
5.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
28
318
0.86
0.31
1.1
1.3
mu/l
23.7
68.9
3.53
22
228
(3025315) Body weight
7
94
0.73
0.30
5.3
4.5
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
103
930
1.08
0.30
1.7
1.8
mmol/l
6.9
6.8
0.08
84
638
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
205
1895
1.05
0.30
2.1
2.0
mg/l
27.0
25.7
0.12
54
507
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
225
2302
0.95
0.30
2.5
5.1
iu/ml
1022.6
787.0
0.11
14
346
(3026692) Albumin [Mass/volume] in Peritoneal fluid
33
279
1.15
0.30
1.2
1.3
g/l
15.4
13.9
0.46
27
217
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
30
337
0.87
0.29
1.7
2.4
nmol/l
194.6
158.3
1.25
25
294
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
32
357
0.87
0.29
1.1
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
137
1419
0.94
0.29
1.8
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
33
367
0.88
0.28
1.2
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
182
1868
0.95
0.28
1.0
1.1
u/ml
1.9
3.5
2.04
80
808
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
83
1.29
0.27
1.1
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
9
114
0.77
0.27
1.7
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1807
17345
1.02
0.27
2.1
2.5
%
21.5
21.6
0.14
1576
14650
(3028626) Oxygen [Partial pressure] in Capillary blood
257
2400
1.04
0.27
2.4
2.7
kpa
8.2
8.2
0.34
236
2225
(3022948) Iron [Moles/volume] in Serum or Plasma
2067
20399
0.99
0.26
2.1
2.4
umol/l
12.9
12.7
0.33
1910
18696
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
72
0.68
0.26
1.0
1.0
—
—
—
0
0
(44806071)
14
166
0.82
0.25
1.1
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
21
174
1.18
0.25
1.3
1.2
ng/l
134.3
73.2
0.55
14
110
(3022475) Manganese [Moles/volume] in Blood
13
102
1.24
0.25
1.6
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
110
1139
0.94
0.24
1.2
1.5
u/ml
30.6
22.2
0.47
14
222
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
31
341
0.89
0.24
1.2
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
12
144
0.81
0.24
11.1
10.6
mmol/l
4.4
4.7
0.26
12
144
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
79
0.74
0.24
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
17
196
0.84
0.23
2.5
2.7
u/field
0.4
0.8
1.94
17
196
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
67
603
1.08
0.23
1.5
1.5
pmol/l
14.8
15.2
0.42
50
505
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
42
452
0.90
0.23
1.7
1.5
mmol/l
7.8
8.1
0.22
24
283
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
35
305
1.12
0.23
1.1
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
5
39
1.25
0.22
1.2
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
171
1742
0.96
0.22
1.5
2.4
u/ml
8244.5
1405.0
—
6
91
(3037556) Urate [Mass/volume] in Serum or Plasma
33
359
0.90
0.22
2.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
285
2872
0.97
0.22
3.7
3.6
mg/l
22.2
23.8
0.36
158
1791
(3021901) Oxygen saturation in Capillary blood
219
2052
1.04
0.22
2.5
2.8
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
14
163
0.84
0.22
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
13
104
1.22
0.22
1.2
1.2
—
—
—
0
0
(3026906) Gabapentin [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
131.4
—
0
5
(3001218) Citrate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
11
0.00
0.21
0.0
3.9
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
36.3
—
0
6
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
76
692
1.07
0.21
1.4
1.8
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
19
159
1.16
0.21
1.2
1.2
—
—
—
0
0
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
13
0.00
0.20
0.0
1.2
—
18.7
—
0
13
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
63
659
0.93
0.20
1.4
1.6
nmol/l
2.2
3.5
1.34
55
534
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
9
109
0.80
0.20
1.0
1.1
mmol/l
8.8
8.3
—
9
109
(4024509)
177
1657
1.04
0.19
1.7
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
58
525
1.08
0.19
2.3
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
673
6681
0.98
0.19
1.5
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
54
488
1.08
0.19
1.9
2.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
57
1.20
0.18
11.9
7.9
—
—
—
0
0
(3012544) pH of Venous blood
1177
11315
1.01
0.18
2.7
3.5
ph
7.4
7.4
—
6
49
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
59
1.16
0.17
1.3
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
67
0.73
0.17
1.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
10
80
1.22
0.16
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
665
6369
1.02
0.16
6.7
8.5
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
8
68
1.15
0.16
1.1
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
11
127
0.84
0.16
1.2
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
34
361
0.92
0.16
1.3
1.8
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
8
69
1.13
0.16
1.0
1.1
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
15
168
0.87
0.16
1.1
1.3
mmol/l
7.4
5.8
—
6
80
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
74
0.79
0.15
1.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
6
74
0.79
0.15
1.2
1.5
u/l
140.0
417.4
—
6
69
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
22
192
1.12
0.15
1.0
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
106
989
1.04
0.15
1.2
1.1
mmol/l
32.3
33.3
0.18
96
818
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
9
79
1.11
0.15
4.4
5.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
94
958
0.96
0.15
1.1
1.1
iu/ml
7.7
9.2
0.28
28
216
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
23
248
0.90
0.14
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
36
324
1.08
0.14
1.4
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
61
629
0.94
0.14
1.2
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
33
296
1.09
0.14
2.9
1.7
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
30
268
1.09
0.14
1.2
1.1
%
78.6
92.7
—
5
58
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
535
5126
1.02
0.14
4.4
4.6
%
1.5
1.6
5.14
509
4813
(3019420) Tryptase [Mass/volume] in Serum or Plasma
73
747
0.95
0.14
1.3
1.6
ug/l
7.0
9.0
0.79
67
677
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
119
1203
0.96
0.13
3.6
3.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
651
6250
1.02
0.13
6.4
8.1
mmol/l
24.6
24.6
0.11
606
5833
(40765096) Chromosome analysis panel by Banding
31
327
0.92
0.13
1.1
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
35
367
0.93
0.13
2.1
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
35
367
0.93
0.13
2.1
2.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
10
114
0.85
0.13
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
223
2227
0.98
0.13
1.2
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
440
4360
0.98
0.13
3.0
3.8
mmol/l
1.4
1.3
0.42
435
4284
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
1010
9945
0.99
0.13
1.3
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
60
555
1.05
0.12
2.4
2.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
27
242
1.09
0.12
1.9
1.8
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
101
948
1.04
0.12
1.2
1.3
mmol/l
2.1
2.2
0.34
93
874
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
124
1248
0.97
0.12
1.3
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
73
743
0.96
0.12
1.2
1.3
mmol/l
5.8
5.8
0.02
67
696
(3029396) Erythrocyte agglutination [Presence] in Blood
16
174
0.90
0.12
2.6
2.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
73
742
0.96
0.11
1.4
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
411
4068
0.98
0.11
1.9
2.2
g/l
38.1
37.7
0.86
330
3419
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
83
777
1.04
0.11
2.0
1.9
u/field
2.4
2.2
0.19
54
530
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
54
553
0.95
0.11
3.7
4.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
147
1393
1.03
0.11
1.3
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
173
0.90
0.11
1.1
1.7
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
10
112
0.87
0.10
2.2
2.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
13
112
1.13
0.10
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
133
1260
1.03
0.10
1.3
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
296
2833
1.02
0.10
2.5
2.9
mmol/l
25.9
25.2
1.54
252
2494
(3018572) Chloride [Moles/volume] in Blood
274
2718
0.98
0.10
6.0
6.2
mmol/l
105.4
104.9
1.13
248
2448
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
38
349
1.06
0.10
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1929
18677
1.01
0.10
2.0
2.4
g/l
2.4
2.4
2.07
1765
17119
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
36
330
1.06
0.10
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
163
1550
1.02
0.10
2.4
2.4
—
—
—
0
0
(3039000) Anion gap in Blood
274
2717
0.98
0.10
5.9
6.2
mmol/l
10.8
11.0
0.70
248
2447
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
5
45
1.08
0.09
1.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
45
460
0.95
0.09
1.2
1.6
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
49
456
1.05
0.09
1.1
3.1
mg/l
7221.3
551.4
0.72
39
300
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
6
54
1.08
0.08
1.0
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
525
5058
1.01
0.08
4.4
4.7
%
0.9
0.9
0.44
497
4748
(3029075) Extractable nuclear Ab panel - Serum
42
429
0.95
0.08
1.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
6
57
1.03
0.08
1.0
1.1
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
5
59
0.83
0.08
1.0
1.4
—
14639.2
—
0
5
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
34
349
0.95
0.08
1.4
1.3
%
46.0
39.9
0.39
24
231
(3036603) Volume of Urine
95
951
0.97
0.08
1.3
1.5
ml
2266.2
1849.8
1.50
22
219
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
119
1187
0.98
0.07
2.2
2.2
u/field
3.6
2.8
0.42
49
471
(3008152) Bicarbonate [Moles/volume] in Arterial blood
783
7688
0.99
0.07
5.6
6.5
mmol/l
25.2
24.9
1.74
733
7149
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
6
70
0.83
0.07
1.0
1.0
u/ml
0.0
0.3
—
6
62
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
57
535
1.04
0.07
1.1
1.1
ng/l
501.6
727.8
0.22
16
114
(3025018) Bordetella pertussis Ab [Titer] in Serum
85
852
0.97
0.07
1.3
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
26
238
1.06
0.07
1.0
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
69
694
0.97
0.07
1.3
1.8
%
108.9
100.2
1.24
63
634
(3008037) Lactate [Moles/volume] in Venous blood
288
2768
1.01
0.07
3.2
3.1
mmol/l
1.5
1.5
0.16
283
2720
(3035285) Chloride [Moles/volume] in Venous blood
164
1568
1.02
0.07
2.4
2.3
mmol/l
105.0
105.5
0.79
164
1559
(3006576) Bicarbonate [Moles/volume] in Blood
34
315
1.05
0.07
4.3
5.9
mmol/l
24.4
25.4
0.95
26
293
(3032868) Hemoglobin electrophoresis panel in Blood
7
81
0.84
0.07
1.3
1.6
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
83
0.82
0.07
1.4
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
164
1569
1.02
0.07
2.4
2.3
mmol/l
4.0
4.0
0.02
164
1560
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
19
172
1.08
0.07
1.1
1.8
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
89
0.88
0.06
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
251
2413
1.01
0.06
2.2
2.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
115
1143
0.98
0.06
1.3
1.4
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
33
307
1.05
0.06
1.3
1.3
nmol/l
88.0
123.7
1.90
25
199
(3027456) Digoxin [Moles/volume] in Serum or Plasma
289
2783
1.01
0.06
3.2
3.3
nmol/l
0.8
0.8
0.95
224
2212
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
91
907
0.98
0.06
1.8
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
10
108
0.90
0.06
1.3
1.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
22
202
1.06
0.05
3.9
6.1
%
67.9
68.4
0.03
17
153
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
100
954
1.02
0.05
1.3
1.3
mmol/l
10.8
11.9
0.61
26
233
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3999
38868
1.00
0.05
2.6
2.8
ng/l
1023.5
1166.2
1.51
3401
33026
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
33
308
1.04
0.05
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
115
1140
0.98
0.05
1.3
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
117
0.92
0.05
6.9
6.7
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
107
0.91
0.05
1.1
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
30
280
1.04
0.05
1.8
2.3
mmol/l
6.1
7.0
1.63
16
170
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
75
715
1.02
0.04
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
14
127
1.07
0.04
1.9
2.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
57
569
0.98
0.04
2.1
2.5
u/l
202.9
212.5
0.68
57
563
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
75
716
1.02
0.04
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
57
543
1.02
0.03
1.9
2.1
ug/min
17.2
67.4
1.45
11
88
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
27
253
1.04
0.03
6.0
5.1
u/l
48.2
44.6
0.16
11
110
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
103
989
1.01
0.03
1.2
1.3
titre
1024.0
435.7
—
5
68
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
37
371
0.97
0.03
1.4
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
17
174
0.95
0.03
1.5
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
33
330
0.97
0.02
1.7
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
134
0.94
0.02
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1121
10942
1.00
0.02
2.7
3.5
mmol/l
2.2
2.1
0.27
934
9115
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
12
110
1.06
0.02
1.3
1.3
ug/l
92.0
121.1
—
6
69
(3024354) Oxygen [Partial pressure] in Venous blood
935
9089
1.00
0.02
2.5
3.0
kpa
4.5
4.5
0.53
899
8817
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1032
10034
1.00
0.01
1.7
1.7
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
37
368
0.98
0.01
1.2
2.0
ug/l
17.4
3.2
0.43
19
226
(3030981) Hyaline casts [#/volume] in Urine by Automated count
631
6134
1.00
0.01
2.5
2.5
e6/l
0.3
0.3
0.74
609
5911
(3051593) INR in Capillary blood by Coagulation assay
60
578
1.01
0.00
7.6
10.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
15
152
0.96
0.00
1.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
122
1195
0.99
0.00
1.1
1.2
nmol/l
348.1
368.0
0.54
105
1011
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
20
189
1.03
0.00
1.3
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1691
16481
1.00
0.00
3.5
4.8
mmol/l
1.0
1.0
0.79
1549
15143
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1125
10965
1.00
0.00
2.7
3.5
kpa
5.8
5.8
0.49
1090
10658
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
2289
22290
1.00
0.00
1.4
1.4
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
17
171
0.97
0.00
1.1
1.1
u/ml
1.4
0.3
0.35
12
105
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
14
133
1.03
0.00
1.9
1.9
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
15
144
1.01
0.00
1.4
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
15
149
0.98
0.00
1.1
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
59
577
1.00
0.00
1.1
1.1
iu/ml
—
3.6
—
0
23
(3012898) Urea [Moles/volume] in Urine
10
101
0.96
0.00
1.1
1.3
mmol/l
167.2
168.0
—
10
88
(3004446) Plasmodium sp identified in Blood by Light microscopy
12
118
0.99
0.00
2.7
2.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
394
3833
1.00
0.00
5.1
5.4
mmol/l
1.3
1.3
0.17
353
3388
(3043238) Trisomy 21 risk [Likelihood] in Fetus
121
1183
1.00
0.00
1.4
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
20
190
1.03
0.00
1.8
2.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
20
198
0.98
0.00
1.8
1.7
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013862) HLA-DP [Type]
5
50
0.97
0.00
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
58
0.84
0.00
1.0
1.3
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
48
1.01
0.00
1.0
1.0
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
5
48
1.01
0.00
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
5
48
1.01
0.00
1.0
1.0
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
63
0.93
0.00
1.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
49
0.99
0.00
1.2
1.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
62
0.94
0.00
1.0
1.3
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
100
969
1.01
0.00
1.2
1.3
titre
30.0
56.9
2.41
12
78
(3045759) Histamine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3002853) Influenza virus B Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
48
1.01
0.00
1.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
68
0.86
0.00
1.2
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
7
77
0.89
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_ERPLUS – Medicines for HER+ breast cancer
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).